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ROLE O                         ROLE OF CRYPTOCHROME IN IGF-1 PRODUCTION AND CALORIE 
RESTRICTION MECHANISM 
 
AMOL S. CHAUDHARI 
ABSTRACT 
 
 
Insulin-like growth factor-1 (IGF-1) is an essential paracrine and autocrine factor for 
tissue homeostasis, growth, and development. Decreased IGF signaling plays an 
important role in mechanisms of calorie restriction (CR) - a lifespan-extending 
dietary paradigm. Recently we demonstrated the interaction between circadian clock 
and CR. The circadian clock is an internal time keeping system which is regulated by 
feeding. We also demonstrated that feeding affects the expression of circadian clock 
genes. Here we report that transcriptional regulators and key components of the 
circadian clock, Cryptochromes (CRY’s) are essential for the CR-mediated 
downregulation of IGF-1 production and signaling. Plasma levels of IGF-1 and liver 
and skeletal muscles production of IGF-1 are significantly reduced in CRY-deficient 
mice. In agreement with reduced IGF-1 signaling, CRY-deficient mice have reduced 
body size and changes in gene expression profile similar to other dwarf mice.  
Downregulation of IGF-1 upon CRY 1,2 deficiency correlates with reduced IGF-1 
mRNA expression and reduced phosphorylation of the STAT5B transcriptional 
factor. We also found that CR downregulates CRY 1 expression on the protein level 
in the liver and skeletal muscles of wild-type mice. CR also results in reduced 
phosphorylation of the transcriptional factor STAT5B through unknown 
mechanisms; in turn, reduced STAT5B activity causes downregulation of IGF-1 
vii 
 
expression. At the same time, phosphorylation of the STAT5B upstream kinase JAK2 
was not reduced, which places CRY activity downstream from JAK2. Finally, CR 
did not downregulate liver IGF-1 expression and plasma IGF-1 levels in CRY -
deficient mice. We found that CRY-deficient mice demonstrate increased expression 
of CISH, a negative regulator of the JAK2-STAT5B pathway. We propose that 
downregulation of CRY’s contributes to impaired STAT5B phosphorylation and 
IGF-1 expression during CR and CR regulate CISH expression through the CRY-
dependent mechanism. Thus, CRY’s link the circadian clock and calorie restriction 
mechanisms regulating STAT5B-dependent IGF-1 expression. The calorie restriction 
reduces the cancer incident by downregulating IGF-1 level but the exact mechanism 
is not known. Our study will provide significant inputs on the mechanism by which 
calorie restriction downregulate the IGF-1, and thus, suggest that it might be possible 
to achieve at least some beneficial effects of CR by targeting the Cryptochrome.   
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CHAPTER I 
 
INTRODUCTION 
 
 
1.1 The Circadian Clock  
We have developed and synchronized our life in a clockwork universe. In our daily 
routine life, we always come across this question, ‘What time is it now?’ Clock rules 
our lives. The layout of our solar systems such as the movements of planets and 
gravity control the clock.  Clock defined our daily routine such as when to sleep, wake, 
eat, play, work and pray. All living organism have tuned their internal clockwork to 
24 hours day and night cycle to adapt Earths 24 hour’s rotation. These adaptations 
allow them to synchronize with behavior, physiology, and metabolism.   
In most organisms, circadian rhythms are the 24 hours endogenous rhythms which 
maintain all feature of the physiology such as blood pressure, body temperature, 
hormonal levels, behavior and metabolism (Gachon et al. 2004; Lowrey et al. 2004). 
In mammals, light is the major zeitgeber to reset circadian rhythms (Dijk et al. 1995). 
The clock is also entrained by another clue such as feeding.  
Research work also revealed that time of feeding is also another important zeitgeber 
that entrains the peripheral circadian clocks located in different organs of our body. It 
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was concluded that central and peripheral clock regulates the physiological and 
behavioral outputs. Disruption of the circadian clock is associated with the 
development of several pathophysiological conditions; aging-related disorders; 
moreover, it is also implicated in reducing longevity (Froy & Miskin. 2010; Fu et al. 
2002; Kondratov et al. 2006; Dubrovsky et al. 2010).    
 
1.2 Historical Background  
It has been reported that plants and animals exhibit the circadian rhythms. In 1729, 
the French astronomer performed the first experiment on biological rhythms (De 
Marian. 1773) which showed that mimosa plant leaves are open during the day and 
are folded at night. The 18th-century Swedish naturalist architect a living clock in 
which garden with flowers opened at various times around the clock (Linnaeus. 1758).  
Charles Darwin also expressed in his book “The power of movement in plants” 
(Darwin and Darwin. 1880) that folded-leaf state of plants at night as “sleep” and 
figure out that it was a way for plants to reduce exposure and preserve the energy. 
Studies from the Karmer and Frisch lab, are the first proof of the existence of a 
biological clock in which they showed that birds and bees can maintain a given 
direction throughout the day using a time-compensated sun compass in navigation 
(Kramer G et al. 1952; Von Frisch K. 1950, 1974). Researchers also proposed that 
circadian systems are conserved throughout evolution. Research work from the 
Pittendrigh lab proved that circadian clocks are temperature independent (Pittendrigh. 
1954). His work concluded that temperature changes did not affect the clock.  Aschoff 
work constructed the “Circadian Rule”, which reveal “that in light-active animals: the 
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spontaneous frequency (Aschoff.1958), the ratio of activity time to rest time (Aschoff. 
1960), and the total activity (Aschoff. 1963) all increase with increasing intensity of 
continuous illumination.” Finally, it was shown that circadian rhythms are present in 
all major groups of organisms (Pittendrigh and Minis. 1964; Evans. 1966). 
 
1.3 Master Clock – suprachiasmatic nucleus 
Initially, these 24-hour processes were seen as part of a time-measuring capacity of 
the organism. However, Colin Pittendrigh, a co-founder of modern chronobiology, 
proposed that there was a distinct light-sensitive oscillator that acted as an internal 
clock for 18 the organism (Pittendrigh, 1960). From this point on chronobiologists 
sought a central master clock within the mammal. To investigate these further, 
researchers ablated several regions of the brain to search for the brain region involved 
in driving circadian rhythm. Research studies on rats with lesions in the 
suprachiasmatic nuclei (SCN) showed that the animal’s locomotor activity results into 
arrhythmic, showing that the SCN is the structure driving circadian rhythms in 
behavior (Moore and Eichler, 1972). The suprachiasmatic nuclei (SCN) are located in 
the brain at the base of the hypothalamus, directly above the optical chiasma. SCN 
consist of about 10-20,000 neurons per nucleus. The same effect of lesions in the SCN 
was observed in other mammals like golden hamsters (Refinetti et al. 1994) and mice 
(Schwartz and Zimmerman. 1991). 
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Figure1-1. The mammalian circadian system and the communication between the 
Master clock and peripheral clock. Light signals the master clock in SCN which in turn 
synchronize the peripheral clocks via hormonal and neuronal signals, SCN also dictates 
rhythms in a time of feeding, and behavior. Food and feeding regimen can directly reset 
the peripheral clocks uncoupling it from the SCN clock. 
 
Later studies clearly defined the SCN as the master clock in mammals came soon after 
the discovery of the (natural) tau mutant golden hamster, exhibiting circadian 
behavior with a periodicity of 20 h (for homozygous animals) as compared to 24 h for 
wild-type animals (Ralph and Menaker. 1988). By transplanting fetal SCN tissue from 
hamsters with a short period to SCN-lesioned wild type recipient’s circadian rhythms 
were restored with a short period, demonstrating that the SCN is the location of the 
master clock. The master clock receives the light input from the retina through the 
retinohypothalamic tract (RHT) that synchronizes internal clock timing to the external 
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light/dark cycle, which it passes on to the peripheral clock via neuronal and hormonal 
pathways. (Pando et al. 2002; Yo et al. 2004).                  
These molecular clocks present in the SCN and clock present the peripheral tissues 
share the same molecular architecture and generate similar circadian rhythms (Yo et 
al. 2004). The synchronization between master and the peripheral clock is necessary 
to maintain rhythms in physiology and metabolism. Although light is the dominant 
cue for the SCN clock, the peripheral clocks are known to be driven either indirectly 
by rhythmic feeding time, sleep/wake cycle or body temperature or directly by the 
feeding regimen (Damiola et al. 2000). (Figure 1-1) 
 
1.4 Photoentrainment- Inputs into the SCN  
To regulate the daily light and dark cycle, the neurons from the SCN (Suprachiasmatic 
nucleus) collect photic information as electrochemical signals. These signals are 
transmitted via direct synaptic connections with the retina, specifically through the 
retinohypothalamic tract (Ralph and Menaker. 1989; Rusak et al. 1989). Several 
studies at molecular and genetic level have been performed to describe the light-input 
pathway for the circadian oscillator in mammals and several candidate photoreceptors 
have been proposed. It is known that light for vision is absorbed by rhodopsin in rods 
and for color by opsins in cones, which are located in the outer layer of the retina 
(Figure 1-2). To investigate whether retinal rods and cones are required for 
photoentrainment, the effects of light on the regulation of circadian wheel-running 
behavior were examined in mice lacking these photoreceptors (Freedman et al. 1999). 
It was concluded that mice without cones or without both rods and cones exhibit 
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normal phase-shifting responses to light, whereas removal of the eyes abolishes this 
behavior.   
Therefore, it was concluded that neither rods nor cones are required for 
photoentrainment, and the eye must contain additional photoreceptors that regulate 
the circadian clock. Studies also have shown that Melanopsin which is an opsin-like 
protein is an attractive candidate for a photoreceptor.  Melanopsin is expressed by a 
subset of mouse and human retinal ganglion cells (RGCs) (Provencio et al. 1998, 
Hattar et al. 2002). 
The RGCs are situated in the inner nuclear layer of the front part of the retina. 
Research studies have shown that Melanopsin project the light signals via the 
retinohypothalamic tract (RHT) to the SCN (Figure 1-2). Studies on Melanopsin-
deficient mice concluded that Melanopsin is required for normal circadian responses 
to the light, as those mice displayed severely attenuated phase resetting in response to 
brief pulses of light (Panda et al. 2002). 
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Figure 1-2. Cellular organization of the retina 
Visual photoreceptors (rods and cones) located next to the pigment epithelium are 
stimulated by light that passes various layers of the retina. Retinal ganglion cells (RGCs) 
are also photosensitive and provide photic input to the circadian system located in the 
suprachiasmatic nucleus (SCN) via the retinohypothalamic tract (RHT). This diagram is 
adapted from Dowling (1997) Encyclopedia of Human Biology, vol. 7 pp 571-87. 
 
1.5 The clock in different mammalian tissues-Peripheral clock  
It is believed that almost every cell within the mammals contains a molecular clock 
but the two-known exception known for this rule is the cells within the thymus and 
testis. In these tissues clock genes expression is not circadian in character and does 
not oscillate with a 12-hour period (Alvarez et al. 2010). Similarly, mouse embryonic 
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stem cells also showed a lack of rhythmicity. It has been also shown that peripheral 
clocks within the peripheral organs with immature or non-differentiated tissues does 
not function properly (Stratmann & Schibler. 2006).    
Molecular oscillators are not only restricted to the master clock, but they are also 
found in other regions of the brain and in most peripheral tissues (Giebultowicz et al. 
2000). It has been found that in peripheral tissue there is a few hours (3-9 h) delay in 
cycle with respect to the oscillation existing in the SCN (Zylka et al. 1998). The 
peripheral clocks of Drosophila can be entrained directly by light via non-ocular 
mechanisms (Plautz et al. 1997) while in mammal’s peripheral oscillators do not 
directly respond to light but are synchronized via neuronal and humoral signals from 
the SCN (Balsalobre et al. 1998). Studies also showed that immortalized fibroblasts 
treated with serum or chemicals activate a variety of known signal transduction 
pathways, exhibit rhythmic expression of several circadian genes persisting for 
several days (Balsalobre et al. 2000; Yagita and Okamura. 2000). Additionally, 
peripheral oscillators also respond to other stimuli (e.g. food availability) 
independently from the SCN (Cermakian and Sassone-Corsi. 2002). Interestingly, it 
was shown that the molecular composition of the circadian clock in the SCN and 
periphery is very similar (Yagita et al. 2001). Therefore, it was proposed that the SCN 
is a master clock that synchronizes the timing of the peripheral oscillators according 
to light input that SCN receives from the environment and in response to these 
peripheral oscillators regulate local rhythms in physiology and behavior (Figure1-1) 
(Reppert and Weaver. 2002; Schibler et al. 2003). 
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          However, studies showed that the function of peripheral clock and specific 
contribution of each molecular component of the clock is highly tissue-specific. This 
is clearer when studies demonstrated differential expression patterns of Clock mRNA 
between tissues. Clock mRNA oscillates within peripheral systems, but it shows 
constitutive expression within the SCN (Lowry et al. 2004). Similarly, Rev-erb (α, β 
and γ) present markedly differing expression patterns across tissues (Sato et al. 2003. 
Akashi et al. 2005).  Ror-α display robust oscillation within the SCN while little 
rhythmic expression is observed in the peripheral tissues. Ror -γ has been shown to 
contribute within certain peripheral clocks; however, is not expressed or functional 
within the SCN (Guillamound et al. 2005). In conclusion, it is important to study 
peripheral clock behavior on a tissue-specific level to fully comprehend their function. 
This is becoming significantly important as an increasing number of diseases are 
associated with circadian clock disruption.  
 
1.6 The Molecular Clock  
Across the kingdoms the basic structural mechanism of the circadian clock is 
ubiquitous. Clock gene and their protein products arranged to form an auto-regulatory 
feedback loop based on transcription and translation. During the past 40 years, dozens 
of genes have been found regulating circadian rhythms. The interplay of these genes 
constitutes the molecular pacemaker. In the center of the map are two interlocked 
transcriptional-translational feedback loops. This is certainly true for the circadian 
clock in Drosophila, Danio Rerio and rodents (Young & Kay. 2001).  
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In mammals, the primary loop consists of four components: Two basic helix-loop-
helix (HLH), Period-Arntl-Single-minded (PAS) transcription factors, CLOCK, and 
BMAL1. CLOCK (or its homolog NPAS2) and BMAL1 heterodimerise and interact 
with E-box cis-regulatory enhancer sequences within the promoters of the genes 
Period (PER 1, 2 and 3) and Cryptochrome (CRY 1 and 2). PER and CRY proteins 
forms heterodimer and translocate back into the nucleus, where they act in a negative 
manner upon the CLOCK: BMAL1 dimers, repressing CLOCK: BMAL1 
transcription activity and thus their own transcription (Gekakis et al. 1998. Kune et al. 
1999. Shermann et al. 2000. Sato et al. 2006). CLOCK: BMAL1 also act within a 
secondary loop, promoting the transcription of members of the retinoic acid-related 
orphan nuclear receptor families, Rev-erb and Ror. REV-ERB (α, β, and γ) and ROR 
(α and β) subsequently bind to retinoic acid-related orphan receptor response elements 
(ROREs) within the BMAL1 promoter, repressing and promoting BMAL1 
transcription respectively (Guillaumond et al. 2005). These transcriptional-
translational feedback falls into approximately ~24 hours rhythms to complete one 
cycle. The timing of these loops is controlled by post-translational modification, such 
as ubiquitination and phosphorylation. Both processes governing the degradation of 
core clock components and the timing of translocation back into the nucleus. These 
posttranslational modifications are thought to be driven by protein kinases, Casein 
Kinase epsilon (CK1ε) and Casein Kinase delta (CK1δ) (Lowry et al. 2000. Akashi et 
al. 2002)     
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Figure1-3. Molecular mechanism of the mammalian circadian clock.  
A current model of the circadian transcriptional-translational loops (TTLs) in mammals. 
CLOCK/BMAL1 activates E‐boxes in promoters of target genes (Pers, CRY s, and 
CCGs). PER and CRY proteins form a complex which inhibits CLOCK/BMAL1. 
Additional loops contain Rev-erbα/β and Rorα which regulate CLOCK and 
BMAL1.Kinase and phosphatase promoting their degradation. 
This figure adapted from https://www.ncbi.nlm.nih.gov/pubmed/25100653 
 
         
 
1.7 Circadian Clock and Human diseases   
The changes in the body energy state are due to the day-night variation in food 
consumption, activity, and rest. Pieces of evidence demonstrated that circadian 
rhythms and human health are tightly interconnected and that disruption in circadian 
rhythms has profound consequences, many times leading to metabolic disease. The 
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disruption circadian alignment has been found at many incidents such as changes in 
the sleep-wake and fasting-feeding cycle. Mostly, these changes or misalignment has 
been to occur during shift-work, during let lag, and in certain circadian rhythm sleep 
disorders. Shift-work has been shown to be a risk factor for health problems such as 
cardiovascular disease, impaired glucose metabolism and obesity (Tenkanen et al., 
1997; Morikawa et al., 2005; Suwazono et al., 2008; Suwazono et al., 2009). It is also 
observed that mice subjected to light exposure during the night and fed exclusively 
during their rest phase show increased body weight (Arble et al. 2009; Fonken et al. 
2010). A Recent study also demonstrated that circadian misalignment has an adverse 
effect on hormonal factors such as glucose and insulin. Therefore, further research is 
needed to determine the underlying molecular mechanisms that cause the negative 
effects induced by the circadian disruption.  
 
1.8 Circadian Clock Proteins  
 CLOCK and BMAL1 are transcription factors and core components of the circadian 
clock. Both the proteins consist of one basic helix–loop–helix (bHLH) domain and 
two PAS (Per-Arnt-Sim) domains. These domains play important role in DNA 
binding and heterodimerization, respectively. The C-terminal of CLOCK protein also 
consists of a characteristically active poly-glutamine repeat.  The complex formation 
induces the phosphorylation and the nuclear localization. The NES (nuclear export 
signal) and NLS (nuclear localization signal) domains are highly conserved in 
BMAL1 and CLOCK. These domains are located adjacent to the PAS domain. In 
addition to various interconnected autoregulatory loops, the additional mechanism 
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regulates and supplement complexity to circadian clock in maintain circadian rhythms 
some of this mechanism are the post-transcriptional modifications, post-translational 
modifications, chromatin remodeling and stability of Clock proteins and intracellular 
localization. (Takahashi et al., 2006).  PERIOD proteins are the member of the 
negative feedback loop; Period proteins are central components of the circadian clock. 
It has been showed that advances or delays of the molecular oscillator by PER proteins 
in the feedback loop occur by controlling the early repressive complex assembly. PER 
proteins consist of two tandemly organized PAS (PER–ARNT–SIM) domains, 
through which they form homo or heterodimers. PER proteins function is also 
modulated by phosphorylation. CKIε has also been shown to control the PER protein 
stability and subcellular localization. It specifically interacts and phosphorylates 
PER1, PER2 and PER3 proteins, regulating each of them in a different manner. The 
members of the nuclear receptor family Rev-erb α/β and ROR are now accepted as 
bona fide components of the core clock. Rev-ERB and ROR proteins belong to the 
retinoic acid-related orphan receptor (ROR) with DNA binding domain recognizing 
ROR elements (A(A/T)NT(A/G)GGTCA). REV-ERBα and RORα compete for 
binding to ROR elements in the BMAL1 promoter region. REV-ERBα acts as a 
negative regulator while RORα acts as a positive regulator of BMAL1 transcription.   
 
The focus of my dissertation is to investigate the physiological role of circadian clock 
protein, Cryptochrome. Therefore, I will discuss the Cryptochrome and its role in the 
molecular pathways in more details.  
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1.9 CRYPTOCHROMES 
A. Discovery of mammalian Cryptochromes 
Cryptochromes are found in many species such as plants, bacteria, and mammals. 
Cryptochromes belongs to photolyase/Cryptochrome family. Cryptochrome is 
structurally similar to flavoproteins and well characterized as blue-light 
photoreceptors where they play important role in UV-induced DNA damage repair 
mechanism (Photolyase), regulate growth (Plant Cryptochrome) and importantly in 
the alignment of circadian clock with daily light/dark cycles (mammalian 
Cryptochrome). Cryptochrome possesses 50% sequence identity to photolyases 
(Todo, T. 1999). Cryptochromes are known to regulate some of the blue-light 
responses including growth and development in plants. Importantly, in mammals, 
Cryptochromes are important to regulate the circadian rhythm by light-independent 
mechanisms in animals (Sancar A. 2000). 
Based on exhaustive biochemical research data, it has been revealed that humans and 
other placental mammals do not have photolyase (Li Y. F, Kim S. T, and Sancar 
A.1993). Cryptochromes have demonstrated both light-dependent photoreceptor 
activity (bacteria, insects, and plants) like photolyase and light-independent 
transcriptional repressor activity (mammalian). The result was unexpected and led to 
a re-evaluation of the previous conclusion. Hsu et al. found that neither this protein 
nor a second ortholog they subsequently discovered had photolyase activity and 
suggested that these proteins must, therefore, perform other blue-light-dependent 
functions in human cells and named them human Cryptochrome 1 and Cryptochrome 
2 (hCRY 1 and hCRY 2).   
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B. Structure and evolution of Cryptochromes  
Photolyase/Cryptochrome is monomeric 50-70 kDa protein composed of two non-
covalently bound chromophore/cofactor (Sancar.2003). One of the cofactors is always 
FAD. The second chromophore is methenyltetrahydrofolate (MTHF)1 in the most 
organism and 8-hydroxy-5-deazariboflavin in a few species that synthesize this 
cofactor. Photolyase plays important role in repairing UV-induced DNA damage 
using violet/blue light (350 –500 nm) as the energy source to initiate the reaction.  
Cryptochrome consist of the photolyase homology region (PHR) within N-terminal 
domain and C-terminal domain consists of the canonical flavin-binding site. The N-
terminal is conserved in both photolyase and Cryptochrome proteins whereas the C-
terminal is somewhat divergent and dispensable for its repressive activity. The C-
terminal domain of Cryptochrome possesses the phosphorylation and nuclear 
localization signal site which can modulate the clock protein functions. It has been 
showed that Cryptochrome activity can be regulated by phosphorylation. 
Cryptochromes are phosphorylated by several kinases such as CKI, MAPK, and 
AMPK. It is concluded that phosphorylation of Cryptochromes by MAPK and CKI 
reduces the repressor activity of Cryptochromes. It is also proposed that the AMPK 
mediated phosphorylation target CRY 1 for FBXL3 mediated degradation thus, 
reducing the CRY 1 stability. The CC helix on the CRY’s structure seems to have an 
important role in its stability. Because this CC helix engages in the interaction with 
both the PERs and the FBXL3, an E3 ubiquitin-ligase. This very well explains the 
stabilization of CRY s when bound to the PERs which restricts the interaction with 
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the FBXL3 (Hirayama & Sassone-Corsi. 2005). 
    
Figure 1-4. Schematic representation of the functional domains present in CRY’s. 
Conserved and unique domain are indicated above, chromophore binding site is indicated 
by vertical dotted lines. CLOCK and BMAL1 binding regions in mouse CRY. 
This figure is adapted from https://www.ncbi.nlm.nih.gov/pubmed/21858120 
 
C. Role of Cryptochrome in circadian clock mechanism    
Both hCRY 1 and hCRY 2 has been found to bind with moderate affinity to DNA and 
with higher affinity to UV light-damaged DNA but have no repair activity (Zhu R S 
et al. 2003).  To understand the biochemical properties of mammalian Cryptochromes, 
a panel of ten mutant mCRY 1 expression constructs was generated, based on domains 
identified at the sequence level that is at the carboxy-terminal 100–120 amino acids 
of mCRY 1, which most distinguishes the protein from mCRY 2 as well as CRY’s 
from other organisms (e.g., Drosophila) and which is lacking in photolyases. Different 
mutant proteins, which include mutations in the nuclear localization signal (NLS) 
domains, deletion of the C-tail, deletion of the coiled-coil, and mutation of tryptophan 
320 to phenylalanine (in photolyase involved in intramolecular electron transport) was 
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performed. Using this panel of mutant constructs, it was concluded that the domains 
involved in protein–protein interactions and subcellular localization of the protein 
located in the carboxyl terminus of mCRY 1. This domain is involved in association 
with mPER2 as well as with BMAL1 (Chaves et al. 2006). Another group of 
researchers performed an experiment with genetically modified mice in which the 
mCRY 1 and/or mCRY 2 genes were inactivated and revealed that the two mouse 
Cryptochromes are part of the molecular clockwork generating behavioral and 
molecular rhythms. Notably, single-knockout mice have opposing circadian 
phenotypes, as evident from the observation that mCRY 1–/– and mCRY 2–/– mice 
display short and long behavioral periodicity, respectively, as measured by voluntary 
wheel-running activity (van der Horst et al. 1999; Vitaterna et al. 1999). Remarkably, 
behavioral analysis of mCRY 1/2 double- knockout mice indicated a complete loss of 
the circadian clock in these animals (van der Horst et al. 1999). Thus, mCRY 1 and 
mCRY 2 proteins not only have an antagonistic clock-adjusting function but are also 
essential for maintenance of circadian rhythmicity.  
The mCRY 1 and mCRY 2 genes are expressed in a circadian manner, whereas 
simultaneous inactivation of the mCRY genes abolishes cycling of mPER1and 
mPER2 expression (Okamura et al. 1999). A key observation was the finding that 
Cryptochromes proteins are much stronger inhibitors of CLOCK/BMAL1-driven 
transcription of E-box-containing reporter genes than mPER proteins (Kume et al.  
1999). This observation placed CRY proteins unequivocally at the core of the 
circadian oscillator and pointed to them as being the most important factors in 
maintaining the negative feedback loop of the molecular oscillator. 
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Figure 1-5. Circadian phenotype of CRY mutant mice  
Representative double-plotted actogram of A) wild-type animals (n=14), B) mCRY 1 
knockout animals (n=9), C) mCRY 2 knockout animals (n=5) and D) mCRY 1 and mCRY 
2 double knockout animals (n=8). Mice were under LD (12:12) and DD conditions. 
Shading indicates darkness and the black vertical lines represent animal activity. This 
figure is adapted from https://www.ncbi.nlm.nih.gov/pubmed/10217146 
 
Interestingly, the function of mCRY 1 and mCRY 2 in the molecular oscillator is not 
exclusively confined to the level of transcription repression; the proteins also have a 
role in the posttranslational control of other core clock proteins. 
Coimmunoprecipitation studies with transiently expressed clock proteins and yeast 
two-hybrid experiments have uncovered direct interactions between mCRY proteins 
and various other core oscillator components (i.e., mPER2, mPER1, CLOCK, and  
 
BMAL1) (Shearman et al. 2000; Yagita et al. 2002; Chaves et al. 2006). In addition, 
immunohistochemical and biochemical studies revealed synchronous circadian 
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patterns of abundance, phosphorylation status, and nuclear localization of mCRY and 
mPER proteins (Lee et al. 2001). Particularly, the observation that mPER2 mRNA 
levels are increased in mCRY 1/2 double-knockout mice, whereas mPER2 protein 
could not be detected in the cytoplasm or the nucleus of SCN neurons (Shearman et 
al. 2000), suggested that mCRY proteins are necessary to stabilize mPER2. Indeed, 
physical interaction between mPER2 and mCRY proteins was shown to inhibit PER2 
ubiquitylation and proteasomal degradation (and possibly changes in subcellular 
localization) of the mCRY-mPER complex (Yagita et al. 2002). Thus far, known 
protein–protein interactions of, as well as CLOCK/BMAL1-mediated transcription 
inhibition by, mCRY proteins have been shown to be independent of light (Griffin et 
al. 1999). 
 
D. Phenotypes of CRY 1–/– and CRY 2–/– Mice  
The analysis of the phenotype of mCRY mutant mice revealed that the mCRY 1 gene 
drives long-period circadian clockworks, whereas the mCRY 2 gene confers short 
periodicity to the circadian oscillator (Okamura et al. 1999; van der Horst et al. 1999). 
It is also proposed that two genes/proteins could be expressed in different circadian 
time windows, CRY 1 and CRY 2 proteins reach the nuclear compartment in a 
synchronous manner (Field et al. 2000; Lee et al. 2001).  It was concluded that two 
proteins have opposing circadian effects because of sequence differences translating 
in different activities in and/or posttranslational regulation of the clock. It was also 
hypothesized that short and long-period phenotypes of CRY 1–/– and CRY 2–/– 
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mutant mice could be the result of alterations in the phosphorylation patterns of PER 
proteins (Vanselow et al. 2006).  
 
E. Biochemical and Physiological properties of Cryptochromes 
a. Role of Cryptochrome in metabolism 
It is well established that Cryptochromes are essential for circadian timekeeping; the 
involvement of CRY’s in numerous additional signaling pathways is still needed to 
be established. Cryptochromes are core clock genes and exhibits rhythmic expression 
in nearly every tissue in the circadian pattern. This time-dependent expression of 
Cryptochromes is known to impart circadian control on the regulation of downstream 
pathways throughout the body. Cryptochrome proteins act as a second messenger 
between the core clock and other cellular processes in which they participate. 
Cryptochromes regulate many of the signaling pathways involved in the maintenance 
of cellular, homeostasis such as metabolism, inflammation, and DNA damage, besides 
regulating CLOCK: BMAL1 complex activity. These pathways help to maintain 
cellular and genomic integrity by sensing the status of the cell such as metabolic and 
genotoxic stress. Genetic ablation or knockdown of Cryptochrome revealed many 
deleterious effects and a large variety of metabolic disturbances. Studies have shown 
that Cryptochrome double knockout mice exhibit a marked reduction in size and body 
weight compared with controls (Bur et al. 2009). Disruption of circadian rhythms is 
correlated with increased incidence of metabolic disturbances (Wang, X. S. 2011). It 
is also known that Cryptochrome double knockout mice show disturbed sugar 
metabolism with hyperglycemia and glucose intolerance, indicating a strong link 
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between the circadian clock protein Cryptochrome and metabolism (Lamia et al. 
2011). Although blood triglyceride levels of Cryptochrome deficient mice are 
reduced, they still develop hepatic steatosis indicating defects in triglyceride 
metabolism (Cretenet et al. 2010). 
Recent studies have shown that Cryptochromes directly regulate glucose homeostasis 
independent of CLOCK: BMAL1-regulated transcription. CRY 1 and CRY 2 have 
been shown to interact with the glucocorticoid receptor (GR) to repress 
glucocorticoid-stimulated changes in transcription (Lamia K. A. 2011). It was 
confirmed that GR-CRY 1 negatively regulates the rate-limiting gluconeogenic 
enzyme, phosphoenolpyruvate carboxykinase 1 (Pck1). Consistent with these 
collective findings, glucose homeostasis is severely disrupted in CRY -deficient mice, 
highlighting the importance of Cryptochromes in metabolic disease.  
 
b. Cryptochrome in DNA damage response 
As mentioned previously Cryptochromes share evolutionary conservation and 
structural similarity to the DNA damage repair enzyme photolyase. It has been also 
shown that Cryptochromes do not directly repair DNA lesions like photolyase, but 
they do interface with pathways that modulate the cellular responses to DNA damage 
(Kang T. H. 2010; Kang T. H. 2009). In mammals, CRY 1 modulates the ATR-
mediated DNA damage checkpoint by interacting with the cell cycle protein 
TIMELESS (TIM) (Lee, T. H. 2014). To date, mammalian TIM is not considered a 
central clock component. Instead, TIM mediates DNA damage signaling in the ATR-
Chk1 pathway to control cell cycle checkpoints. In mammals, Cryptochromes 
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maintain their ability to interact with TIM, where it competes with ATR-Chk1 for a 
binding site on the N-terminus of TIM. Knockdown of TIM attenuates the canonical 
phase advance of the circadian system upon DNA damage insults. The competitive 
mechanism of interactions between CRY 1 and TIM and other clock proteins that 
regulate CRY 1 stability could represent one way in which circadian phase is altered 
in response to genotoxic stress.  
 
c. Cryptochromes in cancer development  
Epidemiological and animal studies show that disruption of circadian rhythms through 
environmental stimuli (light at night or shift work) or genetic means can lead to an 
increase incidence of cancer. The mechanisms by which circadian disruption leads to 
deregulation of cellular homeostasis and cell cycle control are still unknown. It was 
hypothesized that Cryptochromes play an important role in the circadian timing and 
regulate vital metabolic processes as well as the UV-induced DNA damage response. 
Interestingly, Sancar lab’s in vivo study showed that CRY 1−/−; CRY 2−/− mice do 
not show an increase in cancer rate compared to wild-type mice, even after exposure 
to ionizing radiation (Gauger, M. A. 2005).  Further research showed that loss of 
Cryptochrome reduces cancer risk in p53 mutant mice that are more prone to cancer. 
Deletion of Cryptochromes extends the median lifespan of p53−/−; CRY 1−/−; CRY 
2−/− mice by 1.5-fold compared to p53−/− mice (Ozturk N. J. 2009). Studies in triple 
knockout fibroblasts demonstrated that they were more susceptible than p53–/– 
knockout cells to UV-induced apoptosis, implicating Cryptochromes in the 
transmission of p53- independent apoptotic signals in response to DNA damage. 
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Cryptochromes are connected to the inflammatory response as downregulation of 
CRY’s modulates the levels of inflammatory cytokines and the NF-κβ-stimulated 
transcriptional response that sensitizes cells to apoptosis (Lee J. H. 2011).        
 
 
Figure 1-6. Roles of CRY outside of CLOCK: BMAL1 regulation.  
In mammals, CRY s negatively regulates CLOCK: BMAL1 activity to generate a ~24hour 
clock that regulates ~40% of the genome. CRY is also reported to regulate GPCR 
signaling and downstream metabolism through interaction with the GSα subunit to block 
glucagon-stimulated increases in intracellular cAMP (top left). CRY negatively regulates 
the glucocorticoid receptor to maintain glucose homeostasis, partly through regulation of 
Pck1 expression (top right). Interaction of CRY with components of the ATR-mediated 
DNA damage checkpoint control phase shifting of the clock in response to DNA damage 
(bottom left). While ablation of the SCN increases tumor formation in mouse models, 
deletion of Cryptochromes extends lifespan after ionizing radiation in a p53 null 
background (bottom right). 
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This figure is adapted from https://www.ncbi.nlm.nih.gov/pubmed/27891621 
 
1.10 Growth and body size control in mammals  
The animal body plan to build through coordinated cell division, cell differentiation, 
and cell movements. It is also known that hormonal balance and their signaling 
pathway play an important role during development.  Exhaustive research has been 
done to analyze the endogenous mechanisms that control these basic processes. At its 
simplest level, the clock can be considered as a three-part system: a pacemaker that 
generates the circadian rhythm; an input pathway whereby zeitgebers are perceived 
and adjust the phase of the pacemaker; and finally, an output pathway through which 
the pacemaker regulates a wide diversity of physiological processes and behavior 
(Menaker et al. 1978). The discovery of circadian clock mutants has led to the 
identification of core clock genes in a wide range of model organisms, and we now 
have detailed models to explain how they interact to generate clock function. Thus, in 
contrast to earlier beliefs, the clock is not a property restricted to neuronal networks, 
but ticks in every cell and might, therefore, operate well before the establishment of a 
functional nervous system.  Previous and our finding on Cryptochrome double 
knockout mice have a reduced body size and body weight brings us to hypothesize 
that circadian clock gene Cryptochrome may have a different role independent of as 
a part of the circadian clock. The focus of my work is to address 1. What other 
molecular pathways are in under control of Cryptochrome 2. What are the regulatory 
targets of circadian clock protein Cryptochrome? 3. What is the role of Cryptochrome 
in regulating growth?     
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One of the most interesting features among various animals is the differences in size.  
The molecular exact mechanism that controls organ or organ size is not yet known. 
To date, we know that we are larger than a dog or a mouse, but we do not know why. 
We also know that our left eye is exactly the same size as our right eye, and our brains 
or hearts can grow to an exact size big enough to do their job. Many questions on the 
mechanism of size control remain to be answered. Various factors and signaling 
pathways have been studied to uncover the truth controlling the body size and growth.  
For example, GH-IGF1 axis, Mitogens (EGF, PDGF, Survival factors (IL3), Hippo 
signaling pathways.  Our previous investigation on CRY’s deficient mice 
demonstrated that CRY 1,2 -/- mice have reduced and body weight and body size. 
Therefore, we hypothesized that Cryptochrome might involve in GH-IGF1 signaling.   
IGF-1 is the major mediator of Growth hormone action in the body. IGF1 is produced 
in response to GH in liver and around 90% IGF1 produced in Liver. GH-mediated 
JAK2-STAT5B signaling pathway drives the IGF1 expression. It has been shown that 
the IGF-1 promotes growth of muscle, bone, and adipose tissues in mammals 
(Anisimov and Bartke, 2013; Chia, 2014); skeletal muscles are one of the main targets 
of IGF-1 (Figure 1-10). In my dissertation, I am focusing on the role of Cryptochrome 
in IGF1 regulation. 
 
 
                                   
 
 
26 
 
                                                     
 
                               
Figure 1-7. GH-IGF1 axis. GH secreted from pituitary induces the IGF1 production in 
the liver which plays important role in cell proliferation and growth.   
 
 
1.11 IGF-1 System and Signaling  
IGF1 is the mediator of growth hormone action in the body. IGF-I can play an 
important role as circulating hormone as well as tissue growth factor. The liver is the 
major source of IGF-1 production. The IGF-1 production from the liver is a complex 
system and it is known that GH-mediated signaling pathway plays a vital role in 
upregulating IGF-I gene expression. Initially, it was supposed that virtually all IGF-I 
originated in the liver and was transported by endocrine mechanisms to sites of action, 
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but it is now recognized that IGF-I is also synthesized in other organs where it exerts 
autocrine or paracrine effects. Similarly, to IGF-I, IGF-II is also expressed both in the 
liver and in extrahepatic tissues but is not tightly regulated by GH (Hackett et al, 1997; 
Kim et al, 1998). At the surface of target cells, the biological actions of the IGFs are 
mediated by receptors responsible for the transmission to a highly regulated 
intracellular signaling network.  The IGF system comprises the ligands (IGF-I, 
insulin, and IGF-II), their receptors (IGF-I receptor, IGF-IR; insulin receptor, IR; six 
IGF binding proteins (IGFBPs) and their proteases.  
Following IGF-I ligand binding, the intracellular tyrosine kinase domain 
autophosphorylates specific tyrosines on IGF-1R. These proteins then recruit other 
substrates leading to activation of different signaling cascades, including the 
phosphatidylinositol 3-kinase (PI3K)–AKT pathway that stimulates growth. Skeletal 
muscle is the major target of IGF1 signaling. Binding of IGF1 to its receptor leads to 
activation of its intrinsic tyrosine kinase and autophosphorylation, thus generating 
docking sites for insulin receptor substrate (IRS); this is also phosphorylated by the 
IGF1 receptor. Phosphorylated IRS then acts as docking site to recruit and activate 
phosphatidylinositol-3-kinase (PI3K) which phosphorylates membrane 
phospholipids, generating phosphoinositide-3,4,5-triphosphate (PIP3) from 
phosphoinositide-4,5-biphosphate (PIP2). PIP3 acts in turn as a docking site for two 
kinases, phosphoinositide-dependent kinase 1 (PDK1) and AKT, and in turn, AKT 
gets phosphorylated leading to AKT activation. AKT, in turn, inhibit FOXO activity. 
FOXO factors are required for the transcriptional regulation of the ubiquitin ligases 
atrogin-1, also called muscle atrophy F-box (MAFbx) and muscle ring finger 1 
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(MuRF1), leading to the ubiquitylation of myosin and other muscle proteins and their 
degradation via the proteasome. 
 
 
                                       
Figure 1-8. IGF1 signaling in skeletal muscle. IGF1 binding causes auto- 
phosphorylation and activation of IGF1R. Receptor activation stimulates phosphorylation 
of PDK1(Ser241) and AKT (Ser473) results in the inhibition of FOXO transcription 
activity.   
 
1.12 Growth hormone-mediated JAK2-STAT pathway 
Human growth hormone (GH) is a single chain peptide consisting of 191 amino acids. 
Growth hormone is the part of the hypophyseal-pituitary axis. Growth hormone is 
released from somatotroph cells in response to binding of growth-hormone-releasing 
hormone (GHRH) to its receptor and activating gene transcription by cyclic adenosine 
monophosphate-dependent mechanisms. Central and peripheral mechanisms are 
involved in regulating growth hormone's release from somatotroph cells. Growth 
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hormone has multiple actions which play an important role to promote linear growth, 
increased muscle mass and reduce fat stores. Direct actions of GH-mediated by 
binding its receptor, located mostly in the liver and been found in bone, muscle, 
adipose, brain and immune tissues. The growth hormone binding to its receptor 
induces intracellular signaling by a phosphorylation cascade involving the JAK/STAT 
(signal transducing activators of transcription) pathway. Its predominant action is to 
stimulate hepatic synthesis and secretion of IGF-I, a potent growth, and differentiation 
factor. The indirect effects are fulfilled through up-regulating hepatic gene expression 
and production of Insulin-like growth factor-1 (IGF-I). It is also showed that IGF-1 
feedbacks to regulate GH production and secretion from the pituitary (Liu J. L. 1999). 
Clinical study result showed that deficiency in growth hormone or defects in its 
binding to the receptor is seen as growth retardation or dwarfism. GH-deficient 
patients or defect in growth hormone action have abnormal skeletal growth (Melmed 
S. 1995).  
Production of IGF-I in the liver and in other tissues is regulated by growth hormone 
(GH)–dependent control of transcription (Herrington et al. 2000; Herrington and 
Carter-Su. 2001; Rotwein. 2012; Chia. 2014). GH binds its receptor (GHR) and 
induces activation of the receptor-associated tyrosine kinase Janus kinase2 (JAK2). 
JAK2 phosphorylates the intracellular part of GHR, which results in engagement of 
the JAK-signal transducer and activator of transcription (STAT) signaling pathway 
(Lanning and Carter-Su. 2006). Transcriptional factors from the STAT family are 
recruited to the phosphorylated receptor and get phosphorylated on the Tyr residue by 
JAK2 (Herrington et al. 2000; Rotwein and Chia. 2010; Chia. 2014). After 
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dissociation from the receptor, phosphorylated STATs form dimers, translocate to the 
nucleus, and bind to specific sites and regulate transcription. (Figure 1-11)                                     
                            
 
                                  
Figure 1-9. GH-mediated JAK2-STAT pathway. The activation of JAKs after growth 
hormone stimulation results in the phosphorylation of STATs, which then dimerize and 
translocate to the nucleus to activate IGF1 gene transcription. This figure is adapted from 
https://www.ncbi.nlm.nih.gov/pubmed/14668806.  
 
Janus kinases (JAK proteins, JAKs) are receptor-associated protein tyrosine kinases. 
The formation of ligand-receptor complex induces the receptor-associated JAK 
proteins recruitment at the inside of the cell membrane which in turn induces trans-
31 
 
phosphorylation of the JAK protein (Leonard and O'Shea. 1998; Yeh and Pellegrini. 
1999). Four mammalian JAKs have been identified (JAK1, JAK2, JAK3, and TYK2) 
(Duhé and Farrar. 1998). Importantly, JAK2 kinase has been found to play important 
role GH-mediated signal transduction and growth.  The JAK family members consist 
of JH1-JH7 domains. 
 
       
         
Figure 1-10. Domain structure of Janus kinases (JAKs).  
The catalytic activity of the kinase domain JH1 is regulated by interaction with the 
pseudo-kinase domain JH2. JH3-JH7 mediates protein-protein interactions, e.g. receptor 
association. This figure is adapted from https://www.ncbi.nlm.nih.gov/pubmed/11905829 
 
It was concluded that GH promotes the association of JAK2 with GH receptor which 
promotes activation of JAK2 in which JAK2 autophosphorylate itself within tyrosine 
residue and stimulate the phosphorylation of tyrosines of GH receptor (Argetsinger L. 
S. et al 1993). Recruitment of these signaling molecules to GH receptor/JAK2 
complexes initiates a variety of signaling pathways that lead to the regulation of 
transcription of specific genes, cellular metabolic enzymes, and the actin cytoskeleton, 
ultimately leading to GH stimulation of body growth.  
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Signal transducers and activators of transcription (STAT) proteins are the best-
characterized JAK substrates. Seven STAT family members are found in humans, 
STAT 1-4, STAT5A, STAT5B, and STAT6. Across the diversity of receptors that act 
via the JAK/STAT pathway, there is no simple relationship between which JAK 
family members activate which STAT family members.  
Structure of STAT  
           
Figure 1-11. Signal transducer and activator of transcription (STAT) proteins consist 
of six different domains that mediate their interaction with cytokine receptors and upon 
dimerization with DNA.   
This figure is adapted from https://www.ncbi.nlm.nih.gov/pubmed/11905829 
 
STAT5A and STAT5B have been strongly implicated in GH signaling through their 
participation in transcriptional activation of multiple GH-regulated genes. STAT5 has 
recently been shown to contribute to regulating several components of the GH-insulin-
like growth factor 1 (IGF-I) axis, long recognized as fundamental for growth-
promoting actions of GH. Importantly, recent studies showed that the transcription 
factor STAT5B as a key component in acute GH-stimulated IGF-I gene activation 
thus extending previous observations pointing to effects of STAT5B on regulating 
postnatal somatic growth in mice. In summary, The IGF-I gene is a direct target of 
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STAT5B, and studies also revealed that IGF-I concentrations were reduced in 
STAT5B-deficient mice.  
 
1.13 Negative regulation of JAK2-STAT pathway 
Cytokines induce a variety of biological responses by binding to specific cell surface 
receptors and activating cytoplasmic signal transduction pathways, such as the 
JAK/STAT pathway. Although these responses are generally transient, few molecules 
have been characterized that switch the signal off. Several different steps of the signal 
transduction pathway appear to be targeted by negative regulators, including the 
receptor/ligand complex, JAK kinases, and STAT transcription factors. Recent studies 
identified three major classes of the negative regulator: SOCS (suppressors of 
cytokine signaling), PIAS (protein inhibitors of activated STAT's) and PTPs (protein 
tyrosine phosphatases). Many PTPs participate in the regulation of JAKs by 
ubiquitylation (Ub) has been suggested. The physiological significance of protein 
ubiquitylation in the regulation of JAKs remains to be determined. Protein inhibitor 
of activated STAT (PIAS) proteins interacts with STATs in response to cytokine 
stimulation and they inhibit the transcriptional activity of STATs through distinct 
mechanisms. (Figure 1-13)                                            
                                     
34 
 
           
 
Figure 1-12. Negative regulation of the JAK–STAT pathway. JAKs can be negatively 
regulated by suppressor of cytokine signaling (SOCS) proteins, protein tyrosine 
phosphatases (PTPs), such as SRC homology 2 (SH2)-domain-containing PTP1 (SHP1), 
SHP2, CD45 and T-cell PTP (TCPTP), and ubiquitin-mediated protein degradation. 
SOCS proteins, which are induced by cytokines, act as a negative-feedback loop to switch 
off the activity of JAKs. Many PTPs participate in the regulation of JAKs. The regulation 
of JAK2 by ubiquitylation (Ub) has been suggested. The physiological significance of 
protein ubiquitylation in the regulation of JAKs remains to be determined. STATs can be 
negatively regulated by PTPs (such as PTP1B and TCPTP) in the cytoplasm, and by PIAS 
proteins, as well as PTPs (such as TCPTP and SHP2), in the nucleus. Protein inhibitor of 
activated STAT (PIAS) proteins interacts with STATs in response to cytokine stimulation 
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and they inhibit the transcriptional activity of STATs through distinct mechanisms. This 
figure is adapted from https://www.ncbi.nlm.nih.gov/pubmed/14668806 
 
We hypothesized that SOCS’s are the major negative regulators in CRY-
deficient mice. Therefore, I will discuss SOCS’s proteins in more details.  
 
A. SOCS proteins  
The Suppressor of cytokine signaling (SOCS) family consist of 8 SOCS proteins in 
mammals; SOCS1-7 and the alternatively named Cytokine-inducible SH2-containing 
protein (CISH). It has been shown that SOCS1-3 and CISH are predominantly 
associated with the regulation of cytokine receptor signaling. All SOCS proteins can 
regulate receptor signaling through the recruitment of proteasomal degradation 
components to their target proteins. SOCS proteins can directly inhibit JAK kinases, 
binding via their KIR domain to the JAK activation loop to inhibit kinase activity 
(Naka et al. 1997). CISH, SOCS2, and SOCS3 can also inhibit signaling via their 
ability to bind to phosphotyrosine residues typically on receptors, thereby blocking 
access of other SH2-containing signaling molecules. 
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Figure 1-13. Mechanism of action of SOCS. SOCS negatively regulate receptor-
mediated signaling. SOCS’s can inhibit signaling by several mechanisms: a) Degradation 
of receptors or associated proteins via the proteasomal pathway. b) Inhibition of JAK 
tyrosine activity. c) Competition for receptor phosphotyrosine residues thereby blocking 
other signaling molecules. d) Prevention of nuclear translocation of key signaling 
molecules. 
This figure is adapted from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714205/.  
 
A. Structure of SOCS’s  
Each SOCS protein consists of three distinct domains; an N-terminal domain of low 
conservation, a conserved central Src-homology 2 (SH2) domain, and a more highly 
conserved C-terminal domain termed the SOCS box. It has been also concluded that 
the SH2 domains of the SOCS proteins interact specifically with phosphotyrosine 
residues present on their target proteins, including cell surface receptors, imparting on 
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SOCS proteins their target specificity (O’Sullivan et al. 2007). Finally, the SOCS box 
is comprised of two functional sub-domains; a BC box that recruits Elongin B and C 
and a Cul box that mediates Cullin5 binding required for protein degradation.                        
   
Figure 1-14. All SOCS proteins consist of three conserved domains, the N-terminal, 
SH2 and SOCS box domains. The N-terminal domain is the kinase inhibitory region 
(KIR). The SH2 domain is involved in substrate binding via interaction with specific 
phosphotyrosine residues on the target protein. The SOCS box consists of BC box and 
Cul box sub-domains mediate proteasomal degradation.  
This figure is adapted from ttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714205  
 
A. Regulation of SOCS expression  
CISH is the founding member of the SOCS family. The study concluded that CISH 
gene induced by growth hormone (GH) (Adams et al. 1998; Helman et al. 1998; Pezet 
et al. 1999). It was also shown that STAT5A/B KO mice had no detectable CISH 
expression (Teglund et al. 1998; Moriggi et al. 1999). CISH has been shown to be a 
direct STAT5 target gene (Matsumoto et al. 1997; Moriggi et al. 2005). The SOCS1 
expression has also been found to induced by growth hormone. (Adams et al. 1998; 
Hansen et al. 1999). SOCS1 is direct of STAT3. SOCS2 was shown to be highly 
expressed in the fetal kidney as well as adult kidney, lung, testes, liver, pancreatic 
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islets (Dey et al. 1998; Metcaf et al. 2000). SOCS2 is most closely related to CISH 
and like CISH is induced by cytokines that activate STAT5, including GH. SOCS3 
has been shown to be expressed in a wide variety of murine and human tissues. SOCS3 
has been demonstrated to be induced by the cytokines including growth hormone.    
 
B.    Mechanism of regulation GH-mediated JAK2-STA5B pathway 
CISH is known to negatively regulate signaling induced by GH. CISH can bind to the 
same receptor phosphotyrosine sites as STAT5, thereby physically blocking further 
STAT5 docking, which has been demonstrated for the growth hormone receptor 
(GHR) (Verdier et al. 1998; Ram et al. 1999; Hansen et al. 1999). CISH can also 
negatively regulate signaling at the receptor level by facilitating proteasomal 
degradation of activated receptor complexes via interactions between its SOCS box, 
Elongin B/C and Cullin5 (Hanada et al. 2003; Piessevaux et al. 2008). SOCS1 is 
known to regulate signaling via two mechanisms. Firstly, it can bind directly to 
cytokine receptor-associated JAK1, JAK2, and TYK2 to inhibit their tyrosine kinase 
activity via its ESS/KIR domains (Yasukawa et al. 1999; Nicholson et al. 1999). 
However, like other SOCS family members, SOCS1 can also interact with Elongin 
B/C and Cullin5 via its SOCS box, facilitating ubiquitination and proteasomal 
degradation of target substrates (Zhang et al. 1999; Vuong et al. 2004). SOCS2 
primarily exerts its effects by stimulating ubiquitination of target proteins, including 
receptors, such as GHR (Vesterlund et al. 2011), Like its closest homologue, SOCS1, 
the SOCS3 protein can directly inhibit receptor-bound JAKs, although it achieves this 
via a high-affinity interaction between its SH2 domain and a phosphotyrosine residue 
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on the receptor rather than the JAK (Sasaki et al, 2000). SOCS3 also regulates 
signaling via binding site competition.  
 
1.14     Calorie restriction  
A.    History  
Calorie restriction (CR) can be defined as an undernutrition without malnutrition 
(Black et al. 2001; Dhahbi et al. 2004). In pioneering experiments, McCay et al. 
provided reduced caloric input to white rats and successfully demonstrated the effect 
of reducing calorie intake on the total length of life. McCay’s initial studies on rats 
showed that moderate calorie restriction is the only non-genetic method of altering 
longevity and attenuating biological processes associated with aging. Calorie 
restriction paradigm has been found to be effective in various species such as yeast, 
mice, rats, dogs and possibly non-human primates such as squirrel monkeys (Ingram 
et al. 1990; Lane et al. 1999b; Roth et al. 1999; Weindruch and Walford. 1988).  
 
B.    Physiological features 
Calorie restriction has been found to affect various metabolic activities. An interplay 
between the calorie restriction and circadian clock has also been reported. Our lab 
demonstrated that calorie restriction upregulates BMAL1 expression and our lab also 
demonstrated that BMAL1 negatively regulate mTORC1 activity (R. V. Khapre et al. 
2014); thus, increased BMAL1 activity may contribute to the reduction of mTORC1 
activity upon CR.  
40 
 
CR increases SIRT1 activity which is related to a cascade of antithrombotic effects, 
DNA repair, genomic stability, apoptosis, growth and differentiation, inflammatory 
inhibition. Additionally, CR was connected to SIRT1 via an alteration in the 
NAD/NADH ratio; this activity was concluded to have a connection to longevity by 
amplifying overall SIRT1 activity. Furthermore, CR was shown to attenuate the up-
regulation of nuclear factor (NF)-kB, a transcription factor that induces expression of 
tumor necrosis factor in white adipose tissue. (Lin S. J. et al., 2002). Calorie restriction 
is also known to reduce body mass and adiposity, body temperature and metabolic 
rate, blood pressure.  
Calorie restriction also reduces glucose and fasting plasma insulin levels while it 
increases the insulin sensitivity and levels of high-density lipoproteins. Calorie 
restriction also reduces oxidative stress. (Gredilla and Barja. 2005; Gresl et al. 2001; 
Heilbronn and Ravussin. 2003)   
    Extensive research study results revealed that IGF-1 levels decrease upon CR.  In 
contrast, the increased insulin sensitivity and normalized glucose levels in response to 
a CR result in lowered serum insulin and IGF-1. Surprisingly, GH level is not reduced 
upon CR (Bruss et al. 2011), and GH sensitivity is also not affected. The exact 
mechanism of how CR downregulates IGF-1 is not yet known.  
 
1.15 Relationship between Circadian clock and Calorie restriction 
The functional circadian clock is necessary for the beneficial effect of calorie 
restriction. We and others laboratory demonstrated that calorie restriction affects the 
rhythmic expression and amplitude of BMAL11, PER1and PER2 genes in the liver. 
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It has been also shown that calorie restriction also affects the expression of several 
clock genes in the SCN (Mendoza, et al). Thus, calorie restriction regulates circadian 
clock gene expression in different organisms and in different tissues and might affect 
both central and peripheral clocks. Studies also investigated if circadian clocks play 
any role in the calorie restriction effects on metabolism. Disruption of the circadian 
clock through the knockout of the core clock genes significantly compromised the 
beneficial effects of calorie restriction including the effect on longevity in both 
Drosophila and mice. Thus, these studies established that calorie restriction and 
circadian clock mechanisms are interlinked. 
 
1.16 Role of Cryptochrome in IGF1 production and calorie restriction 
mechanism 
In this dissertation, based on our preliminary results that CRY-deficient mice have 
reduced the IGF1 level, we are hypothesizing that Cryptochrome might play important 
role in IGF1 regulation. We are also investigating the role of Cryptochrome in calorie 
restriction-mediated downregulation of IGF1.   
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CHAPTER II 
 
MATERIALS AND METHODS 
 
 
 
 2.1 Experimental Animals 
 
Wild-type and CRY 1, 2−/− mice were previously described (Vitaterna et al., 1999). 
Mice of all genotypes were of C57B6J background. Mice were maintained on the 
12:12 light: dark cycle with lights on at 7:00 am. All groups had unrestricted access 
to the 18% protein rodent diet (Harlan) and water. All tissue collection experiments 
were performed on 5-month old mice. For all experiments, at least three animals of 
each genotype and gender were used, with at least three animals per time point. For 
all experiments, animals were euthanized using CO2 chamber and all studies were 
performed with approval from and within the guidelines of the Institutional Animal 
Care and Use Committee of Cleveland State University. 
 
2.2 RNA isolation and analysis of mRNA expression  
For gene expression studies, tissues were collected every 4 h throughout the day and 
stored at −80°C. Total RNA was extracted from frozen tissue, using Trizol 
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(Invitrogen) reagent as per manufacturer’s instructions and some modifications. 
Briefly, for every piece of tissue 1 ml of Trizol reagent was used. Tissues were 
homogenized with the pestle (Sigma-Aldrich) for at least 5 minutes or until the entire 
tissue was homogenized. This was done keeping tubes on ice. Tubes were spun at 40C 
at 11500 rpm for 10 min. Supernatants were transferred into new tubes and incubated 
at room temperature for 5 minutes. After adding 200 µl chloroform (Fischer 
Scientific), tubes were shaken vigorously and incubated for 2-3 minutes at room 
temperature. After spinning for 15 minutes at 11500 rpm at 40C, the aqueous phase 
was transferred to a new tube. The RNA was precipitated by adding 500 µl 
isopropanol. RNA was washed using 70% ethanol and the pellet was air dried for 5 
minutes. The pellet was re-suspended in 30 µL of RNase-free water. 
 
Measurement of RNA concentration 
RNA concentration was measured using Nanodrop spectrophotometers. We used 
RNA’s free water to adjust blank reading and dilution. We diluted RNA final 
concentration to 500ng/uL.  RNA integrity was checked on 1% agarose gel run at 90 
V for 30 minutes. 
 
Analysis of mRNA expression 
Following quantification, a 20µl reverse transcription reaction contained 1 μ g of 
RNA, 50 ng of 50 uM random hexamer (N8080127, Invitrogen), 10 mM dNTP 
(DD0058, Biobasic), and 0.1 M DTT. It was then reverse transcribed by reverse 
transcriptase PCR machine using 200 u/μl of SuperScript® III Reverse Transcriptase 
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(18080- 044, Invitrogen) as per the manufacturer’s instructions. Incubation conditions 
used were: 65°C for 10 minutes followed by incubation on ice for 1 minute; 25°C for 
5 minutes; 50°C for 60 minutes; Inactivate the reaction by heating at 70°C for 15 
minutes. RNA quantification was performed using qPCR with Universal Syber Green 
mix (1725125, BioRad). The reaction was carried out in triplicates for the gene of 
interest and in duplicates for the normalizing controls, such as 18s rRNA or GAPDH, 
using CFX96 qPCR Detection System (BioRad) with 50 ng of cDNA. Thermal 
cycling conditions used were according to the instructions of SYBR Green mix 
protocol and relative mRNA abundance was calculated using the comparative delta-
Ct method. Melting curve analysis was used for confirming the product specificity. 
The primer pair was tested for the efficiency that was calculated by standard curve 
analysis using standard serial dilutions method. Primers used for the analysis of 
expression are presented in Table I. 
 
 
 
 
 
 
 
 
 
 
45 
 
Table I. Primers for qPCR 
Gene Ref No Product 
length 
Primer Location 
18s NR_003278.3  
69 
Forward   GCT TAA TTT GAC TCA ACA 
CGG GA 
1235-
1258 
Reverse    AGC TAT CAA TCT GTC AAT CCT 
GTC 
1281-
1305 
IGF1 NM_00111127
4.1 
 
138 
Forward   GAG ACT GGA GAT GTA CTG 
TGC 
520-541 
Reverse    CTC CTT TGC AGC TTC GTT TTC 637-658 
Myogenin 
 
NM_031189.2 
 
 
 
129 
Forward   AAC CCA GGG GAT CAT CTG 
CTC AC 
595-618 
Reverse    GTT GGG CAT GGT TTC ATC 
TGG GAA G 
699-724 
 Murf1 NM_00103904
8.2 
66 Forward    GTG AAG TTG CCC CCT TAC AA 564-584 
Reverse     TGG AGA TGC AAT TGC TCA GT 607-630 
CISH NM_00131735
4.1 
90 Forward     CCG ACT GGA CTC CAA TTG CT 307-325 
Reverse      CTG CAC AAG GCT GAC CAC 
AT 
361-397 
IGFBP3 NM_008343.2 70 Forward     GAG TGT GGA AAG CCA GGT 
TGT C 
516-318 
Reverse      GCA TGG AGT GGA TGG AAC 
TTG 
565-586 
SOCS3 NM_007707.3 119 Forward     GGT TCT GCT TTG TCT CTC CTA 
TG 
1987-
2010 
Reverse      TCC CTC AAC TCT CTG CCT 
ATT 
2085-
2106 
SOCS2 
 
NM_00116865
5.1 
92 Forward     TCC CTC GTC TTA TGC AAC 
TAA TC  
1551-
1574 
Reverse      GGA TCT CAT GGT GAT GGT 
TCT T  
1621-
1643 
SOCS1 
 
NM_00127160
3.1 
138 Forward     TAA CCC GGT ACT CCG TGA CT 806-826 
Reverse      CTC CCA CGT GGT TCC AGA 
AA 
924-944 
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2.3 Analysis of protein expression and phosphorylation 
 
Western blotting was done on the liver and skeletal muscle samples pooled 
together from three different mice at each time point for each diet. For tissue lysates 
preparation, frozen liver and skeletal muscle pieces were lysed in 300ul of cell 
signaling lysis buffer (Tris pH 7.5, NaCl, 0.5M EGTA, 0.5 M EDTA, Triton-x 100, 
Na4P2O7, β-glycerophosphate, 1M Na3VO4). 10ul Protease/Phosphatase Inhibitor 
Cocktail (Cell Signaling Technology, Beverly, MA, USA) per ml of lysis buffer was 
added just before use. Tissues were lysed with the sonicator (Fischer Scientific Model 
100) for 5-10 seconds on ice. Lysates were centrifuged at 10000 rpm for 12 mins at 
4ºC. The supernatant was separated and used for protein concentration determination 
and lysates were then stored at -80ºC.Protein concentration was determined by 
Bradford protein assay kit according to the manufacturer’s protocol using UV-
spectrophotometer. Lysates were then denatured by boiling on dry bath for 10 mins 
using 2x loading dye (300 mM Tris HCl PH 6.8, 10% SDS, 50% Glycerol, 10% 2-
mercaptoethanol, 0.0025% Bromophenol blue) and cell signaling buffer to adjust the 
equal concentration of protein in all the lysates. 45 ug of protein was loaded on 3–8% 
tris-acetate and 4–12% bis-tris gels (Invitrogen). Proteins were separated initially at 
90V and then at 145V. Proteins were transferred electrophoretically onto 
Polyvinylidene Difluoride membrane (Thermo Scientific 88518) (PVDF) at 110 mA 
for 70 min using transfer buffer containing 20% methanol, Tris Base 3g/L, Glycine 
14.4g/L. Ponceau stain was used to check for equal loading of proteins. After transfer, 
membranes were blocked for non-specific binding in 5% non-fat dry milk in TBS-T 
buffer (Tris Base 60.57 g/L, NaCl 87.66 g/L PH adjusted to 7.4 with HCl and 0.1% 
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Tween-20) on a shaker for 1 hour at room temperature. Further blots were incubated 
with specific primary and secondary antibodies as described in the table below (Table 
II). Protein analysis was performed using Clarity TM Western ECL Substrate (BIO-
RAD) and quantification was done using Scientific Imaging Film and Odyssey FC 
imaging system (LI-COR). 
Antibody table: II 
Antibody Cat No Company 
Phospho-STAT5B (Tyr 
699) 
9351 Cell signaling 
Phospho-jak-2 (Tyr1007) 4406 Cell signaling 
phospho IGF-1R β (Tyr 
1135/1136) 
3024 Cell signaling 
Phospho AKT (Ser 473) 4060 Cell signaling 
Phospho PDK1 (Ser241) 3061 Cell signaling 
Total AKT 9272 Cell signaling 
Total STAT5 9363 Cell signaling 
Total PDK 3062 Cell signaling 
Total IGF-1R 3018 Cell signaling 
IGF-1 Ab36532 Abcam 
B-Actin A5441 Sigma 
Antibody Cat No Company 
SOCS-1 3950 Cell signaling 
SOCS-2 2779 Cell signaling 
SOCS-3 2923 Cell signaling 
CISH 8731 Cell signaling 
CRY 1 21414 Cell signaling 
CRY 2 sc-130731 Santa Cruz Biotechnology  
 
 
 
48 
 
  
2.4 Measurement of the plasma IGF-I level 
Blood/Plasma Collection  
We sacrificed the mice in a CO2 chamber and performed necropsy afterward 
to collect blood. Plasma separated by centrifuging blood samples at 6000 rpm for 20 
min at 4°C.   
Measurement of plasma IGF1 
Plasma samples were collected every 4 h throughout the day and stored at −80°C. 
Plasma IGF-I levels were determined using a RayBio Mouse IGF-I 96-well plate 
enzyme-linked immunosorbent assay (ELISA) kit. Plasma samples were diluted 50-
fold with the solution provided by the manufacturer. Sandwich ELISA was done using 
two different antibodies; the second antibody was conjugated with biotin. For 
detection, the manufacturer-provided streptavidin-conjugated horseradish peroxidase 
and TMB substrate were used for the colorimetric reaction, and optical density was 
detected at 450 nm. Manufacturer-provided mouse IGF-I was used to generate the 
standard concentration curve; starting concentration was 2 ng/ml, with serial dilutions. 
All experimental samples and standards were run in duplicate on the same plate; 
experiments were repeated three times with different plates. The intraassay coefficient 
of variation was between 4 and 9% for different plates; interassay coefficient of 
variation was 12%. The detection limit for IGF-I measurement was 4 pg/ml. 
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2.5 Statistical analysis 
For all experiments, we used at least three animals for every time point for each 
feeding type and each genotype. Two-way ANOVA was performed for analyzing the 
effect of feeding vs time of the day on mRNA and protein levels. This was followed 
by Bonferroni correction for calculating the p-value for pairwise comparison at each 
time point for statistically significant difference. IBM SPSS Statistics 20 and 
GraphPad Prism Version 5.04 software packages were used for statistical analysis. P 
< 0.05 was considered as a statistically significant difference. Data are shown as 
average +/- standard deviation (SD).  
 
Inter-assay calculation  
The same high and low IGF1 controls are run in duplicates on two different plates to 
monitored plate-to-plate variation. The plate means for high and low are calculated 
and then used to calculate the overall mean, standard deviation, and % CV. Overall % 
CV = (SD of plate means ÷ mean of plate means) x 100. The average of the high and 
low % CV is reported as the inter-assay CV. 
 
Intra-assay calculation  
IGF1 concentrations are measured in duplicate. The % CV for each sample is 
calculated by finding the standard deviation of results 1 and 2, dividing that by the 
duplicate mean, and multiplying by 100. The average of the individual CVs is reported 
as the intra-assay CV. 
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CHAPTER III 
 
CRYPTOCHROMES REGULATE IGF-1 PRODUCTION AND SIGNALING 
THROUGH CONTROL OF JAK-2 DEPENDENT STAT5B 
PHOSPHORYLATION. 1 
 
Amol Chaudhari et al. 
 
3.1Abstract  
Insulin-like growth factor (IGF) signaling plays an important role in cell growth and 
proliferation and is implicated in the regulation of cancer, metabolism, and aging. 
Here we report that IGF-I level in blood and IGF-I signaling demonstrates circadian 
rhythms. Circadian control occurs through Cryptochromes (CRY’s) transcriptional 
repressors and components of the circadian clock. IGF-I rhythms are disrupted in 
CRY-deficient mice, and the IGF-I level is reduced by 80% in these mice, which leads 
to reduced IGF signaling. In an agreement, CRY-deficient mice have reduced body 
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weight (∼30% reduction) and organ size. Down-regulation of IGF-I upon CRY 
deficiency correlates with reduced IGF-I mRNA expression in the liver and skeletal 
muscles. IGF-I transcription is regulated through growth hormone–induced, JAK2 
kinase mediated phosphorylation of transcriptional factor STAT5B. The 
phosphorylation of STAT5B on the JAK2-dependent Y699 site is significantly 
reduced in the liver and skeletal muscles of CRY -deficient mice. At the same time, 
phosphorylation of JAK2 kinase was not reduced upon CRY deficiency, which places 
CRY activity downstream from JAK2. Thus, CRY’s link the circadian clock and JAK-
STAT signaling through control of STAT5B phosphorylation, which provides the 
mechanism for circadian rhythms in IGF signaling in vivo.  
 
1. As it appears in the Molecular Biology of the Cell Journal, 2017 Mar 15;28(6):834-
842. doi: 10.1091/mbc. E16-08-0624 
 
3.2 Introduction  
We found that CRY-deficient mice develop dwarfism similar to other models of 
dwarfism with a reduced level of circulating IGF-1. The main action of Growth 
hormone is the promotion of growth. IGF1 is the major mediator of growth hormone 
action. A number of mutations that alter the GH/ IGF-1 axis have been identified in 
mice and humans and all of them are marked as a dwarf. Mutations in mice have 
growth hormone deficiency resulted into a reduce IGF1 production and IGF1 
signaling. We hypothesized that Cryptochrome might play role in regulation of IGF1 
production and signaling.  
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3.3 Materials and Methods  
Details of the Animal experiment, mRNA, Protein analysis and measurement of 
plasma IGF-1 and statistical analysis have been explained in Chapter II. 
 
 
3.4 Results  
 
Cryptochromes are the component of the circadian clock and many processes are 
oscillating across the day, it was important to monitor the effect at several times across the 
day cycle. We assayed the effect of Cry 1,2-/- on the expression and signaling pathway 
throughout the day.   
 
 
CRY 1,2−/−  mice develop dwarfism  
 
We noticed that CRY 1,2−/− mice are smaller than wild-type (WT) mice of the same 
age (Figure 3-1a). The sizes of 5-mo-old WT and CRY 1,2−/− males are compared; 
a similar size difference was observed in female mice. We decided to investigate the 
difference in size in more detail. Figure 3-1b presents growth curves of male mice of 
both genotypes and Figure 3-1c for females. The difference between genotypes is 
seen already at weaning (3 wk of age); the observed difference was statistically 
significant for all ages. The weight of male CRY 1,2−/− mice was ∼70–75% of the 
weight of WT males; the weight of female CRY 1,2−/− mice was ∼65–70% of the 
weight of WT females (the difference changed with age). CRY 1 and CRY 2 genes 
are partially redundant; therefore, we checked whether a deficiency of either of them 
would be sufficient to induce dwarfism. Body weights of CRY 1−/− and CRY 2−/− 
mice at three different ages (Figure 3-1d for males and Figure 3-1e for females) 
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were similar to the body weight of WT mice. Thus, deficiency of both CRY 1 and 
CRY 2 genes is necessary for body size reduction. 
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Figure 3-1. CRY 1, 2−/− mice have reduced body weight and size. (a) CRY 1, 2−/− males 
are smaller than WT males of the same age. (b) CRY 1, 2−/− males (red squares) have 
reduced body weight compared with WT (blue diamonds) males (N = 16 for each 
genotype). (c) similar results were observed for females.  The difference between 
genotypes is statistically significant (p < 0.001) at all ages, starting at 10 d of age. Weight 
of WT (blue bars), CRY 1−/− (red bars), CRY 2−/− (green bars), and CRY 1, 2−/− (purple 
bars) males (d) and females (e) at three different ages (N = 6 for every age group for every 
genotype). *Statistically significant difference between genotypes (p < 0.05). 
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We also checked whether the size and weight reduction are proportional to the 
reduction of the weights of some particular organs and tissues. We measured the 
weights of all major organs in 5-mo-old animals, when both WT and CRY 1,2−/− 
mice reached their adult size. As shown in Figure 3-2 a, b for males and 3-2 c for 
females, all major organs, including brain, liver, heart, and kidneys, were 
proportionally reduced in their size and weight; therefore, we conclude that CRY 
1,2−/− mice are proportionally smaller than WT mice.  
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Figure 3-2. The weight of visceral organs is reduced in CRY 1, 2−/− males and females. 
Organ weights were assayed for WT (blue bars) and CRY 1, 2−/− (red bars) for 5-mo-old 
males and females (N = 16 for each genotype); the difference between genotypes is 
statistically significant (p < 0.001). 
 
                        
 
 
 
 
 
 
 
 
 
       
 
 
 
 
 
 
 
 
a 
b c 
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CRY  1,2 -/- mice have a reduced production of IGF-I 
Reduced activity of the somatotropic (GH/IGF-I) axis is one of the major causes of 
dwarfism in rodent and humans (Bartke and Brown-Borg. 2004; Chia. 2014). We 
assayed the levels of IGF-I in the plasma of WT and CRY 1,2−/− mice. We observed 
that in WT mice, the levels of the circulating IGF-I demonstrated a statistically signifi-
cant daily oscillation, with the highest value at zeitgeber time ZT2–ZT6 and the lowest 
value at ZT14–ZT22 (Figure 3-3 a). We observed a significant reduction in the levels 
of the circulating IGF-I in CRY 1,2−/− mice at all six-time points tested (Figure 3-3 
a). The circulating IGF-I level was reduced by ∼60–80% for CRY 1,2−/− (depending 
on the time of the day). Thus, similar to other models of dwarfism, a reduced level of 
circulating IGF-I correlated with the reduced body size of the CRY 1, 2−/− mice 
(Bartke and Brown-Borg. 2004).  
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Figure 3-3. CRY’s deficiency affects IGF-I level in plasma and tissues. (a) Daily rhythms 
of plasma IGF-I in WT AL (blue diamonds) and CRY 1, 2−/− AL (red squares) males (N 
= 3 per time point). (b) Plasma IGF-I levels for WT (blue bars), CRY 1−/− (red bars), 
CRY 2−/− (green bars), and CRY 1, 2−/− (purple bars) males at ZT6 and ZT18 (N = 6 
per time point).  
 
 
 
 
           
 
 
             
 
 
 
 
 
 
CRY 1−/− and CRY 2−/− mice did not demonstrate any reduction in body size; 
therefore, we decided to assay whether deficiency of both CRY 1 and CRY 2 is neces-
sary for the effects on the circulating IGF-I. We compared plasma IGF-I levels for 
WT and single or double CRY’s knockouts at two times of the day, ZT6 and ZT18, 
which corresponded to the high and low levels of plasma IGF-I in WT mice. We found 
a 
b 
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a 30% reduction of the IGF-I level in CRY 1−/− mice at ZT6 (compare with 80% 
reduction in CRY 1,2−/− mice; Figure 3-3 b). There was no difference between WT, 
CRY 1−/−, and CRY 2−/− at ZT18 and no difference between WT and CRY 2−/− at 
ZT6. Thus, deficiency of both CRY’s genes is necessary for down-regulation in the 
circulating IGF-I level, which correlates well with the effects of CRY’s deficiency on 
the body size. Thus, we observed significant down-regulation of the circulating IGF-
I levels in CRY 1,2−/− mice.  
 
The major source of the circulating IGF-I is the liver (Yakar et al. 1999); therefore, 
we compared the levels of the IGF-I protein in the livers of WT and CRY 1, 2−/− 
mice (Figure 3-4 a). In WT mice, the liver IGF-I level displayed oscillations (with 
the highest level of IGF-I expression at ZT18–ZT2), and CRY 1,2 deficiency resulted 
in the reduction of liver IGF-I levels (the difference between the genotypes was sig-
nificant at three of six-time points). Many other tissues also produce IGF-I, and, al-
though IGF-I from these sources does not significantly affect the levels of the circulat-
ing hormone, it still plays an important role in paracrine signaling (Liu et al. 1998). 
Therefore, we also determined the IGF-I level in skeletal muscle (Figure 3-4 b). In 
WT, the level of skeletal muscle IGF-I was significantly lower at ZT10 than at other 
time points. Similar to the effect in the liver, we observed significant down-regulation 
of skeletal muscle IGF-I in CRY 1,2−/− mice (the difference between the genotypes 
was significant at all time points except for ZT10). Thus CRY 1,2 deficiencies resulted 
in down-regulation of IGF-I production in different tissues. 
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Figure 3-4. Representative Western blotting (pooled extracts from three mice per time 
point) of IGF-I expression in the liver figure 3-4 a (left) and skeletal muscle figure 3-4 b 
(right) of WT and CRY 1, 2−/− male mice.  Quantification of IGF-I in the liver (left) and 
skeletal muscle (right) of WT AL (blue diamonds) and CRY 1, 2−/− (red squares) male 
mice (N = 3 per time point). The quantification data for the liver and skeletal muscles are 
presented as relative arbitrary units.  
                        
 
 
 
 
 
 
 
 
 
 
 
 
 
IGF-I signaling is reduced in CRY 1,2−/− mice 
IGF-I promotes the growth of muscle, bone, and adipose tissues in mammals 
(Anisimov and Bartke. 2013; Chia. 2014); skeletal muscles are one of the main targets 
of IGF-I. We decided to see whether IGF-I signaling is affected in skeletal muscles of 
a  b 
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CRY 1,2−/− mice. The receptor for IGF-I is the tyrosine kinase IGF-IR (Kavran et al. 
2014). Binding of IGF-I to IGF-IR leads to receptor activation and auto-
phosphorylation on Y1137/1138 in mouse (Y1135/1136 in human IGF-IR; Ullrich et 
al. 1986). We compared IGF-IR phosphorylation skeletal muscles of WT and CRY 
1,2−/− mice. In skeletal muscles of WT mice, IGF-IR phosphorylation significantly 
oscillated during the day, with the highest level of phosphorylation at ZT6–ZT10, in 
agreement with the highest level of the circulating IGF-I. The level of Y1137/Y1138 
phosphorylation was significantly reduced in CRY 1, 2−/− muscles, again in 
agreement with significantly reduced IGF-I in plasma. PDK1 and AKT are protein 
kinases that act downstream of IGF-IR (Schiaffino and Mammucari. 2011). They are 
not direct targets of IGF-IR but are phosphorylated and activated upon IGF-I binding 
to IGF-IR. We assayed the phosphorylation of PDK1 on S241 and AKT on S473. In 
WT mice, PDK1 S241 phosphorylation oscillated during the day, with the highest 
level at ZT10–ZT14, which correlated with IGF-IR Y1137/1138 phosphorylation. 
There was an additional peak of high PDK1 S241 phosphorylation at ZT2. AKT-S473 
phosphorylation was high at the dark phase of the day; thus, AKT phosphorylation 
was delayed compared with IGF-IR phosphorylation or PDK1 phosphorylation. In 
skeletal muscles of CRY 1,2−/− mice, phosphorylation of both PDK1 and AKT was 
significantly reduced (reduction by 30–70% for PDK1 and by 60–80% for AKT, 
depending on the time of the day). Of interest, AKT phosphorylation was still 
rhythmic in skeletal muscles of CRY 1, 2−/− mice, with a high level of 
phosphorylation at night.  
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Figure 3-5 (a, b, c, d, e).  Representative Western blotting (pooled extracts from three 
mice per time point) of phospho–IGF-IR on Y1137/1138, PDK1 on S241, and AKT on 
S473 in skeletal muscle of WT (blue diamonds) (a) and CRY 1, 2−/− (red squares) male 
mice(b). Quantification of phospho–IGF-IR on Y1137/1138 (c), PDK1 on S241 (d), and 
AKT on S473 (e) in skeletal muscle of WT (blue diamonds) and CRY 1, 2−/− (red 
squares) male mice (N = 3 per time point). 
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IGF-I signaling is evolutionarily conserved; in many organisms, reduction of IGF-I 
signaling leads to activation of the transcriptional factor FOXO. We assayed the 
expression of FOXO targets Murf1 and Myogenin in skeletal muscles of WT and CRY 
1, 2−/− mice (Figure 3.5 f & g respectively). We found that expression was up-
regulated at ZT14–ZT22 for Murf1 and at ZT2 and ZT10–ZT22 for Myogenin. These 
results are in good agreement with reduced IGF-I signaling. Of interest, we also found 
that expression of the FOXO target genes significantly oscillated across the day in 
both WT and the circadian mutant, with different patterns, suggesting circadian clock–
dependent and –independent effects of time of the day.  
        
 
Figure 3-5 (f & g). mRNA expression of FOXO transcriptional targets Murf-1 (Figure f) 
and Myogenin (Figure g) in skeletal muscle of WT (blue diamonds) and CRY 1, 2−/− 
(red squares) male mice (N = 3 per time point). *Statistically significant difference 
between genotypes (p < 0.05). The light was on at ZT0 and off at ZT12.  
 
 
 
f g 
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Data in Figure 3-5 proposes that IGF-I signaling is significantly reduced in skeletal 
muscles of CRY 1, 2−/− mice. Thus, deficiency of CRY s resulted in reduced plasma 
IGF-I levels and reduced tissue IGF-I levels and IGF-I signaling in skeletal muscles, 
which may be a reason for the observed reduced body size of CRY 1, 2−/− mice.  
 
STAT5-dependent regulation of IGF-I expression is disrupted in the liver and 
skeletal muscles of CRY 1, 2−/− mice  
Reduced levels of IGF-I in the plasma and tissues of CRY 1, 2−/− mice indicate that 
production of IGF-I is compromised in these mice. We assayed the expression of IGF-
1 on the mRNA level across the circadian cycle in the liver of CRY 1, 2−/− mice and 
compared it with the expression in the liver of WT mice. As shown in Figure 3-6 a, 
IGF-1 mRNA expression in the liver of WT mice significantly changed during the 
day, with the highest expression between ZT14 and ZT22 and the lowest expression 
at ZT2–ZT6. CRY’s deficiency resulted in a significant reduction of IGF-I expression  
in the liver (the difference was significant at all six-time points). In skeletal muscle of 
WT mice (Figure 3-6 b), the IGF-I mRNA level did not show any significant rhythms 
across the day, whereas in skeletal muscle of CRY 1, 2−/− mice, expression was 
reduced at all six-time points, which correlates with the reduced IGF-1 protein level 
in skeletal muscles. Thus, reduced IGF-I mRNA expression may contribute to the 
observed reduced IGF-1 protein level in the tissues of CRY 1, 2−/− mice. 
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Figure 3-6. IGF-I mRNA expression is down-regulated in the liver (a) and in skeletal 
muscle (b) of CRY 1, 2−/− mice.   
 
 
           
 
 
 
 
 
 
 
 
 
 
 
 
The transcriptional factor STAT5B is the major regulator of IGF-I transcription 
(Herrington et al. 2000). STAT5B activity is regulated by phosphorylation: 
phosphorylated STAT5B is transported from the cytoplasm to the nucleus and drives 
the expression of its target genes (Herrington et al. 2000). We assayed the levels of 
STAT5B phosphorylation on Y699 (used as a marker of STAT5B activation). We 
found that in the liver of WT mice (Figure 3-7), STAT5B phosphorylation 
significantly changed across the day, with the lowest phosphorylation level at ZT2, 
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which correlates with the lowest level of IGF-I mRNA transcription, and the highest 
phosphorylation level at ZT10 and ZT18, which correlates with the highest IGF-I 
mRNA level.  
 
 
 
Figure 3-7 ( a, b, c, d). Representative Western blotting (pooled extracts from three mice 
per time point) of phosphorylation of STAT5B on Y699 in the liver (a) and skeletal 
muscle (c) of WT and CRY 1, 2−/− male mice. (b) Quantification of phosphorylation of 
STAT5B on Y699 in the liver of WT (blue diamonds) and CRY 1, 2−/− (red squares) 
male mice. (d) for Skeletal muscle.   
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Of interest, the level of total STAT5B protein did not change significantly across the 
day, which suggests that regulation occurs predominantly on the level of 
phosphorylation. In the liver of CRY 1, 2−/− mice, STAT5B phosphorylation was 
significantly reduced. We also observed some small reduction in the level of total 
STAT5B in the liver of CRY 1, 2−/− mice, but this reduction was not significant 
compared with the effect on STAT5B phosphorylation. The difference in 
phosphorylation was dramatic even after normalization on total protein level (the 
quantification of relative STAT5B phosphorylation presented in (Figure 3-7). In 
skeletal muscles, we observed similar effects of CRY’s deficiency on STAT5B 
phosphorylation (Figure 3-7). In WT, STAT5B phosphorylation oscillated across the 
day, with the highest level at ZT10-ZT14. Phosphorylation was statistically sig-
nificantly reduced in CRY 1, 2−/− at ZT10 and ZT14.                   
 
We also assayed the expression of other known transcriptional targets of STAT5B—
acid-labile subunit (ALS) and IGF-binding protein 3 (IGFBP-3; Woelfle and Rotwein. 
2004). As shown in Figure 3-7, ALS (e) and IGFBP-3 (f) expression were signifi-
cantly reduced in the liver of CRY 1, 2−/− mice at several times of the day, in 
agreement with reduced STAT5B transcriptional activity. 
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Figure 3-7(e & f). Daily rhythms of ALS (e) and IGFBP-3 (f) mRNA expression in the 
liver of WT (blue diamonds) and CRY 1, 2−/− (red squares) males.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STAT5B is phosphorylated by the protein kinase JAK2. JAK2 kinase is activated by 
GHR upon binding to GH. Activated JAK2 can be monitored by assaying JAK2 
phosphorylation on Y1007. Data on JAK2 phosphorylation on T1007 in the liver are 
presented in Figure 3-8 a. In the liver of WT mice, the level of phosphorylation 
changed across the day with low amplitude. In the liver of CRY 1, 2−/− mice, we also 
e 
f 
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observed daily changes in JAK2 phosphorylation. The pattern of JAK2 
phosphorylation was different compared with WT, but the statistical analysis did not 
reveal a significant difference.  
In skeletal muscles of WT mice, JAK2 phosphorylation showed some moderate 
changes (Figure 3-8 b). Of importance, we did not detect any reduction in JAK2 
phosphorylation in the tissues of CRY 1, 2−/− mice: on the contrary, we observed a 
significant increase in the phosphorylation at several time points; therefore, the 
reduced phosphorylation of STAT5B was not a consequence of reduced JAK2 
phosphorylation. 
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Figure 3-8. Representative Western blotting (pooled extracts from three mice per 
time point) of phosphorylation of JAK2 on Y1007 in the liver (a) and skeletal muscle 
(b) of WT and CRY 1, 2−/− male mice. quantification of phosphorylation of JAK2 on 
Y1007 in the liver of WT (blue diamonds) and CRY 1, 2−/− (red squares) male mice (N 
= 3 per time point). *Statistically significant difference between genotypes (p < 0.05). 
The light was on at ZT0 and off at ZT12. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liver Skeletal muscle   a   b 
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Expression of CISH is up-regulated in the liver of CRY 1, 2−/− mice 
Proteins from the suppressors of the cytokine signaling (SOCS) family are negative 
regulators of JAK2 signaling. SOCS1, SOCS2, SOCS3, and cytokine-inducible SH2-
containing protein (CISH or CIS) have been implicated in the control of the 
GHR/JAK2/STAT5B pathway. We analyzed the expression of these proteins in the 
liver of WT and CRY 1, 2−/− mice (Figure 3-9). We did not detect any significant 
changes in SOCS2 expression. Expression of SOCS1 and SOCS3 was reduced at 
some times of the day (at ZT2 for SOCS1 and ZT10 for SOCS3). Expression of CISH 
was significantly upregulated at all time points in the CRY -deficient liver, and this 
change in expression correlated with reduced STAT5B phosphorylation and could be 
one of the contributing factors.  
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Figure 3-9. The expression of CISH is up-regulated in the liver of CRY 1, 2−/− mice. (A) 
Representative Western blotting (pooled extracts from three mice per time point) of 
expression of SOCS1, SOCS2, SOCS3, and CISH in the liver of WT and CRY 1, 2−/− 
male mice. (B) Quantification of expression of SOCS1, SOCS2, SOCS3, and CISH in the 
liver of WT (blue diamonds) and CRY 1, 2−/− (red squares) male mice (N = 3 per time 
point). *Statistically significant difference between genotypes (p < 0.05). The light was 
on at ZT0 and off at ZT12. 
b 
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To further understand the mechanism of regulation, we also assayed the expression of 
mRNA for these genes (Figure 3-10). We found that, in agreement with protein data, 
expression of SOCS2 mRNA was not significantly affected by CRY deficiency. 
Expression of SOCS1 and SOCS3 genes was reduced at some time points. This down-
regulation of expression was not surprising; indeed, the transcription of these genes is 
positively regulated by STAT5B and therefore their expression is expected to be 
reduced under conditions of low STAT5B activity. The expression of CISH was 
significantly increased across the day, which suggests that CRY’s known tran-
scriptional repressors might regulate CISH on the level of mRNA expression.  
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Figure 3-10. Effect of CRY deficiencies on the expression of SOCS and  
CISH mRNA in the liver. Daily profiles of mRNA expression of indicated  
SOCS family member genes in the liver of WT (blue diamonds) and CRY 1, 2−/− (red 
squares) male mice (N = 3 per time point). *Statistically significant difference between 
genotypes (p < 0.05). The light was on at ZT0 and off at ZT12. 
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3.5 Discussion 
CRY deficiency and dwarfism  
We observed that CRY 1, 2−/− mice developed dwarfism, manifested by reduced 
weight and size of all major organs and the body. There are several models of 
dwarfism in mice, which are associated with reduced IGF-1 secretion and reduced 
IGF-1 signaling (Bartke and Brown-Borg, 2004; Quarrie and Riabowol, 2004). CRY 
1, 2−/− mice represent a novel model of dwarfism. Indeed, Ames and Snell's mice 
lack cells producing GH in the pituitary; both mice do not produce detectable GH and 
do not produce prolactin and thyroid-stimulating hormone. Mice with a mutation in 
GH-releasing hormone receptor, called “Little” mice, have significantly reduced GH 
levels. Thus, for all of the aforementioned models, reduced IGF-1 production is 
secondary to reduced GH level. GHR- deficient mice (Laron mice) have increased 
circulating GH level but are resistant to the action of GH due to the absence of the 
receptor. These mice were developed as an animal model of human Laron dwarfism 
syndrome. Thus, in contrast to Ames, Snell, or Little mice, both Laron, and CRY1, 
2−/− mice have reduced IGF-1 but normal GH levels. The difference between CRY1, 
2−/− mice, and Laron mice, is that Laron mice do not have GHR and downstream 
signaling; in addition, they lack the GH-binding protein, which is a product of GHR 
processing.  
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Cryptochromes regulate CISH expression  
We found that CISH expression is significantly increased in the liver of 
Cry1,2-/- mice, which correlated with reduced STAT5B phosphorylation and reduced 
body size of these animals. Previously it was shown that mice overexpressing CISH 
in the liver have STAT5B phosphorylation and transcriptional activity, they have 
reduced weight and body size, therefore, resembling Cry1,2-/- mice. It is reasonable 
to hypothesize that reduced size of Cry1,2-/- mice is due to overexpression of CISH.  
CISH is a member of SOCS protein family, proteins in this family suppresses 
the GH/GHR/JAK2 signaling through several different mechanisms. The possible 
mechanisms by which CISH act are (1) by suppressing JAK2 kinase activity; (2) by 
targeting JAK2 for proteasomal degradation; (3) by inhibiting binding of STAT5B to 
phosphorylated GHR. We did not detect any significant reduction in JAK2 total 
protein level or phosphorylation, we proposed that in the liver of Cry1,2-/- mice CISH 
regulates STAT5B phosphorylation by inhibiting the interaction of STAT5B with 
GHR.  
How CRY’s can regulate CISH expression? Interestingly, CISH, SOCS1, and 
SOCS3 are known transcriptional targets of STAT5B. The reduced phosphorylation 
and transcriptional activity of STAT5B in CRY 1,2 -/- mice correlated with the 
reduced mRNA expression of SOCS1 and SOCS3 genes, which is in an agreement 
with their regulation by STAT5B. However, the increased mRNA expression of CISH 
in CRY 1,2 -/- mice do not correlate the reduced STAT5B activity. The exact 
molecular functions of CRY’s are unknown, it was reported that they can suppress the 
transcriptional activities of several transcriptional factors: circadian clock BMAL1: 
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CLOCK transcriptional complex (Kume et al. 1999), glucocorticoid receptor (Lamia 
et al. 2011) and CREB (Zhang et al. 2010). We performed preliminary bioinformatic 
analysis of CISH promoter region and found two conserved retinoic acid-related 
orphan receptor response elements, these elements are regulated which suggest that 
the expression might under control of Circadian Clock.   
Do CRY’s suppress CISH transcription through direct interaction with some 
regulatory elements in CISH gene or indirectly through the control of other regulators 
is a subject for future research.   
 
Circadian disruption, circadian clock proteins, and IGF1 expression  
The important question is if the circadian clock disruption will affect IGF-1 
production. Recently, we found that CR-mediated effects on IGF-1 plasma levels are 
impaired (Patel et al. 2015) in the another model of the circadian clock deficiency - 
BMAL1-/- mice (Bunger et al. 2000). However, the effect of BMAL1 deficiency was 
rather opposite to the effect of CRY’s deficiency: CR did not significantly 
downregulate circulating IGF-1 levels in BMAL1-/- mice. BMAL1 regulates 
expression of CRY 1 and CRY 2 (Gekakis et al. 1998; Hogenesch et al. 1998); in turn, 
CRY’s inhibit BMAL1-containing transcriptional complexes (Kume et al. 1999), 
thus, these proteins play opposite role in the circadian clock mechanism and in the 
IGF-1 expression control. Impaired regulation of IGF-1 in two circadian clock 
mutants supports the circadian control of IGF-1 production.  
 
 
78 
 
Physiological significance of circadian rhythms in IGF-1 production  
We found serum level of IGF-1 oscillated during the day and the expression 
of Igf-1 mRNA was also rhythmic in the liver and skeletal muscles. Circadian rhythms 
in IGF-1 level correlated with rhythms in IGF signaling in the skeletal muscles. What 
can be a physiological importance of these rhythms? In mammals feeding, activity 
and rest are periodic, therefore, the nutrient supply is periodic and their consumption 
for physical activity is periodic. At the same time, concentrations of the nutrients in a 
body fluid, while having some degree of fluctuation, are relatively constant. Tissues 
must switch from anabolic to catabolic processes to maintain this balance of nutrients. 
Cell growth and proliferation requires a significant amount of resources. It is 
extremely important to coordinate nutrient consumption by different tissues during 
different phases of the day to avoid the energy collapse. Indeed, if all tissues will start 
to proliferate during the time of physical activity, cells might run out of nutrients. 
Therefore, in multicellular organisms, cell proliferation in addition to nutrient 
concentrations, is regulated by multiple extracellular signals such as growth factors 
and hormones and intracellular checkpoint. IGF-1 is important anabolic hormone, 
which promotes cell proliferation, continuously high level of IGF-1 can be dangerous, 
we hypothesized that the circadian clock regulates the IGF-1 production to coordinate 
cell proliferation in different tissues with organism physiology and metabolism.   
 
Figure 3-11. Model of regulation of IGF-I expression by CRY’s in response to GH 
stimulation. Solid lines represent previously reported activation of STAT5B 
phosphorylation by JAK2 and suppression of this phosphorylation by CISH members of 
the SOCS family. CRY’s might directly interact with JAK2-containing complexes and 
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stimulate JAK2 activity toward STAT5B; CRY’s might recruit STAT5B to the 
JAK2/GHR complex, and CRY’s might also suppress CISH expression/activity. Thus, 
CRY’s stimulates STAT5B phosphorylation and activation, which in turn drives IGF-I 
expression in the liver and other tissues. 
 
 
 
         
 
      
                                                               
 
 
 
 
     
The previous study also revealed that CISH overexpression in the liver has been to be 
associated with reduced body weight and suppressed STAT5B activity (Matsumoto, 
A. et al., 1999).  
We also cannot exclude the other possible mechanisms illustrated in Figure 3-11. One 
possibility is that CRY’s directly interact with JAK2, STAT5, or GHR and either 
suppress JAK2 kinase activity or prevent the formation of the GHR/JAK2/STAT5 
complex, which is necessary for STAT5 phosphorylation (Herrington et al. 2000). We 
hypothesized that CRY might involve in the regulation of CISH expression.  CRY’s 
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act as transcriptional repressors and suppress the expression of genes controlled by 
the BMAL1: CLOCK transcriptional complex (Kume et al. 1999). CRY’s also 
modulates the transcriptional activity of glucocorticoid receptor (Lamia et al. 2011) 
and CREB (Zhang et al. 2010). CRY’s, known transcriptional suppressors, might 
control CISH mRNA expression through direct or indirect interaction. Further study 
will determine the molecular mechanisms of CRY-dependent regulation. 
 
Future implications  
This model system is vital to answering questions about the importance of 
Cryptochromes in the regulation of IGF-I production. Once this system can be 
established further modification of this system may help to answer different questions.  
As a long-term goal of this project would be to find out how CRY’s regulate the 
expression of CISH on the mRNA and protein levels.  As we found that increased 
expression of CISH can be a contributing factor to the observed reduced STAT5B 
phosphorylation and reduced IGF-1 transcription. The future aim is to determine the 
importance of Cryptochrome to promote transcription of CISH.  
To further confirm that reduced body size and weight in CRY-deficient mice is due to 
the reduce IGF1 level. We will cross CRY 1,2 -/- mice with mice overexpressing IGF1 
level. We expect that it will restore the body weight. OR we will cross CRY 1,2-/- 
mice with IGF1 negative mice, where we expect that there will be no further reduction 
in body weight.     
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Summary  
Proposed model for Cryptochrome involved in regulation of IGF-1 production via 
JAK-2 dependent STAT5B phosphorylation. This study found Cryptochrome play an 
important role independent of regulating circadian rhythms. This study also suggests 
Cryptochromes are necessary for growth and development.  
The foregoing study found:  
I. Cryptochrome deficient mice develop dwarfism and reduced in body weight.  
II. Cryptochrome deficient mice have reduced IGF-1 production and IGF-1 signaling 
in skeletal muscle.  
III. Cryptochrome involved in the regulation of IGF-1 production via JAK2- 
dependent STAT5B phosphorylation.  
IV. Cryptochrome might involve in regulation of CISH expression    
 
 
 
 
 
 
 
 
 
 
 
82 
 
 
 
 
 
 
 
 
CHAPTER IV 
 
ROLE OF CRYPTOCHROME IN CALORIE RESTRICTION MEDIATED 
DOWN-REGULATION OF IGF-1 PRODUCTION AND SIGNALING  
 
AMOL S. CHAUDHARI 
 
4.1 Abstract 
Decreased IGF-1 production and signaling plays an important role in mechanisms of 
calorie restriction (CR) - a lifespan-extending dietary paradigm. The IGF-1 expression 
is controlled by the transcriptional factor STAT5B, whose activity is regulated 
through growth hormone receptor-dependent phosphorylation by Janus kinase 
(JAK2). STAT5B phosphorylation and IGF1 mRNA expression is reduced under CR 
through unknown mechanisms. Here we report that transcriptional repressor and 
circadian clock component Cryptochrome (CRY) is essential for the CR-mediated 
downregulation of IGF-1. CRY controls STAT5B phosphorylation and IGF-1 mRNA 
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expression by suppressing CISH. CR leads to significantly reduced CRY 1 protein 
level and the induction of CISH expression on both mRNA and protein levels, which 
correlates with down-regulation of STAT5B phosphorylation and activity. In 
agreement with that, CR does not down regulate IGF-1 expression in the liver and 
plasma IGF-1 levels in CRY-deficient mice. Thus, CRY links the circadian clock and 
calorie restriction mechanisms by regulating STAT5-dependent IGF-1 expression. 
 
4.2 Introduction  
Calorie restriction is a dietary intervention that delays aging in many species (Fontana 
et al. 2010; Taormina and Mirisola 2014). It was proposed that the anticancer effects 
of calorie restriction are due to decrease in the activity of the somatotropic axis, and 
specifically to the reduced production and secretion of the insulin-like growth factor 
1 (IGF-I) (Ruggeri et al. 1989; Dunn et al. 1997; Carter et al. 2002). Upon CR, 
expression of IGF-I mRNA in the liver is reduced (Herrington and Carter-Su 2001; 
Herrington et al. 2000), which correlates with reduced STAT5b phosphorylation and 
activity. However, molecular mechanisms connecting CR, STAT5B, and IGF-I 
expression are still not well determined (Thompson et al. 2014).  
We demonstrated that the Cryptochromes (CRY’s) are involved in the control of IGF-
1 production through the control of GHR/JAK2 mediated phosphorylation of 
STAT5B. Mice deficient for CRY expression have significantly reduced the level of 
circulating IGF-1 in the blood and reduced IGF signaling in the skeletal muscles. The 
phosphorylation of STAT5B is also reduced in the tissues of these mice, while JAK2 
phosphorylation was not reduced, which is similar to the effects of CR on 
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GHR/JAK2/STAT5 signaling. We hypothesize that Cryptochrome might involve in 
calorie restriction-mediated downregulation of IGF1 level.   
 
4.3 Materials and Method  
Experimental animals  
CRY  1,2 -/- mice and BMAL1-/- mice were previously described (Vitaterna et al. 
1999; Bunger et al. 2000). Mice were on the C57B6J background. Animals were 
maintained on the 12:12 light: dark cycle with lights on at 7:00 am, and fed the 18% 
protein rodent diet (Harlan). The ad libitum (AL) group had unrestricted access to 
food. Calorie restriction (CR) was started at 3 months of age. For the first week, 
animals have been on 10% restriction, for the second week on 20% restriction and on 
30% restriction for the rest of the experiment. The CR group received their food once 
per day at ZT14 (two hours after light off). After the two months of CR, tissues were 
collected at six different time points across the day. All groups had unrestricted access 
to water.  All tissue collection experiments were performed on 5 months old mice. For 
all experiments, three animals of each genotype, gender, feeding regimen and time 
point were used. All the animal studies were performed with approval from the 
Institutional Animal Care and Use Committee (IACUC) of Cleveland State 
University. The care and use of mice were carried out in accordance with the 
guidelines of the Institutional Animal Care and Use Committee (IACUC) of the 
Cleveland State University. 
 
85 
 
Details of the mRNA, Protein analysis, and statistical analysis have been explained in 
Chapter II. 
 
4.4 RESULTS: (Unpublished)  
CR leads to a reduced level of the CRY 1 protein 
CR affects expression and activity of several circadian clock genes in the liver (Patel 
et al. 2015). We measured the level of the CRY 1 protein in the liver and skeletal 
muscles of wild-type mice on AL and 30% CR regimes (Figure 4-1 a). In both liver 
and skeletal muscle, the expression of CRY 1 demonstrated significant changes during 
the day under both AL and CR feeding conditions. 30% CR resulted in 70 – 90% 
(depending on time point) down-regulation of CRY 1 protein level in the liver; the 
difference was significant at all tested time points. In the skeletal muscles, we also 
detected a significant (30-80% depending on the time point) down-regulation of the 
CRY 1 protein. Thus, CR resulted in down-regulation of CRY 1 expression in two 
tested metabolically active tissues. The effect of CR on the CRY 1 protein was 
different from the effect on the CRY 1 mRNA expression (Figure 4-1 c), in the liver 
we observed some increase in the expression at two time points, in the skeletal 
muscles we observed downregulation at ZT22. Thus, regulation CRY 1 expression by 
CR occur on both mRNA and the posttranscriptional level and mechanisms might be 
tissue specific.  
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Figure 4-1. CR leads to down-regulation of tissue CRY 1 on protein but not mRNA 
level. 
 
  
 
 
 
 
 
 
 
           
 
 
 
                                                                               
(a) Representative Western blotting and (b) quantification CRY 1 expression in the liver 
(left panels) and skeletal muscles (right panels) of WT AL (blue diamond) WT 30% CR 
(green triangle) male mice. Representative WB pooled extracts from 3 mice per time point 
for treatments were used, for quantification, the extracts from individual animals (N=3 
per time point) were analyzed separately and average and errors were calculated. (c) 
mRNA expression of CRY 1 in the liver (left panel) and in the skeletal muscles (right 
panel) of WT AL (blue diamond) WT 30% CR (green triangle) male mice (N=3 per time 
b 
c 
a 
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point). * - The statistically significant different difference between the genotypes 
(p<0.05). The light was on at ZT0 and off at ZT12. 
 
We also investigated the CRY 2 expression in liver and skeletal muscle. In liver, CRY 
2 level is significantly changed during the day while there were no changes in skeletal 
muscle. Interestingly, CRY 2 level significantly increased upon 30% CR at the protein 
level in the liver. While in skeletal muscle the CRY 2 level increased at only at ZT2 
and ZT6 (Figure 4-2 a). Thus, CR resulted in up-regulation of CRY 2 expression in 
two tested metabolically active tissues. The CR results in increase CRY 2 mRNA 
expression at all tested points in the liver and skeletal muscle. (Figure 4-2 c), Thus, 
CR regulates CRY 2 expression at mRNA and the posttranscriptional level. 
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Figure 4-2. CR upregulates CRY 2 at protein and mRNA level. (A) Representative 
Western blotting and (B) quantification CRY 2 expression in the liver (left panels) and 
skeletal muscles (right panels) of WT AL (blue square) WT 30% CR (green triangle) male 
mice. Representative WB pooled extracts from 3 mice per time point for treatments were 
used, for quantification, the extracts from individual animals (N=3 per time point) were 
analyzed separately and average and errors were calculated. (C) mRNA expression of 
CRY 2 in the liver (left panel) and in the skeletal muscles (right panel) of WT AL (blue 
diamond) WT 30% CR (green triangle) male mice (N=3 per time point). * - The 
statistically significant different difference between the genotypes (p<0.05). The light was 
on at ZT0 and off at ZT12. 
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CRY 1,2 -/- mice have a reduced food intake 
To investigate if CRY’s are a part of CR mechanisms directly we decided to apply 
30% CR to CRY 1,2 -/- mice. When we measured food intake of male and female 
mice we found that ad libitum (AL) fed CRY  1,2 -/-  ate about 20-30% less of food 
compared with AL fed wild-type mice as shown on (Figure 4-3 a) for male mice and 
similar results were obtained for female mice. We reported recently that CRY 1,2 -/- 
mice are smaller than wild-type mice of the same age (Chaudhari et al. 2016) and this 
reduced food intake correlates with the reduced weight. Indeed, when we calculated a 
relative food intake (the food intake divided by the body weight) we found that CRY 
1,2 -/- mice consume more food per gram of the body weight. Interestingly that an 
increased food intake was reported in other circadian clock mutants, thus, reduced 
food intake was not caused by the disruption of the circadian clock in these mice, but 
rather unique for CRY deficiency. When CRY 1,2 -/-  and wild-type mice were 
subjected to CR both genotypes demonstrated similar changes in their body weights. 
After transfer to CR, the body weight of mice of both genotypes decreased for a few 
weeks and then stabilized. Relative changes in body weight induced by 30% CR are 
presented in Figure 2B and absolute changes are presented in Supplementary Figure. 
Interestingly, the stable body weight of WT mice on 30% CR was close to the body 
weight of CRY  1,2 -/- AL mice of the same age (Figure 4-3 b), which was in a good 
agreement with 20-30% voluntary reduced food intake for CRY  1,2 -/-  mice on AL 
diet. The relative food intake for wild-type mice on CR was increased in agreement 
with previously published data, at the same time, the relative food for CRY  1,2 -/- 
mice on CR was decreased (Figure 4-3 c).  
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Figure 4-3.  (a) Food intake for male mice, WT AL male (Blue diamonds) and CRY AL 
male (Red squares), (b) Body weight of WT AL (Blue diamonds), WT CR (Green 
triangle), CRY  1,2 -/- AL (Violet square), CRY  1,2 -/- CR (Dark Blue). (c) Relative food 
intake of WT CR (Green triangle), CRY  1,2 -/- AL (Red square), CRY  1,2 -/- CR (Dark 
Blue).    
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CRY-dependent and independent effects of 30% CR on rhythms in gene 
expression 
It is known that CR significantly changes the gene expression landscape (Swindell 
2007). And we recently reported the effect of 30% CR on circadian rhythms in gene 
expression. To study if CRY’s are involved in this CR-mediated changes we 
compared the mRNA expression of several genes, known to be affected by 30% CR, 
in the liver of WT and CRY 1,2 -/- mice on both AL and CR diet across the circadian 
cycle. Three of these genes: PER1, PER2, and BMAL1 are the circadian clock genes 
and four genes: FMO3, MUP 4, CYP4A14A, and CYP4A12B are not the components 
of the clock.  As it was previously reported in the wild-type mice all three tested 
circadian clock genes showed circadian rhythms in the expression and their 
expressions were significantly induced by CR at multiple time of the day (Figure 4-
4. A, B, C). In CRY 1,2 -/- mice under AL conditions the expressions of these genes 
were not rhythmic in agreement with previously published data; under CR conditions 
the expression of PER1become rhythmic and the expressions of BMAL1 and PER2 
were still arrhythmic. 30% CR induced the PER1expression in both genotypes in a 
similar way, a significant induction was observed at ZT10 and ZT14. In CRY 1,2 -/- 
mice CR did not have such strong effect on PER2 or BMAL1 expression as in WT 
mice; for the PER2 expression significant changes were observed at ZT10, but it was 
a downregulation, not an up-regulation as in WT mice, for BMAL1 expression some 
induction was observed only at ZT22. Thus, CR regulated BMAL1 and PER2 
expressions in CRY-dependent manner and PER1expression CRY independently. We 
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proposed that the effect of CR on circadian clock genes expression is Cry dependent 
and independent mechanism.  
 
                     
           
Figure 4-4. Effect of calorie restriction on rhythms of circadian clock genes. mRNA 
expression of core clock genes (a) PER1, (b) PER2, (c) BMAL1.  WT CR (Green 
triangle), CRY 1,2 -/- AL (Red square), CRY  1,2 -/- CR (Dark Blue). Data represent 
mean ± SD; statistically significant (p < 0.05) effects of the feeding (analyzed by two 
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ways ANOVA) at a given time point are indicated by (a)- between WT AL and WT CR 
groups, (b)- WT AL and CRY  1,2 -/- AL, (c)- WT CR and CRY  1,2 -/- CR, (d)- CRY  
1,2 -/- AL and CRY  1,2 -/- CR. Light and dark bars at the bottom represent light and dark 
phase of the day. ZT0 is the time when the light is on and ZT12 is the time when the light 
is off. 
 
30% Calorie restriction led to a dramatic upregulation (more than 300 folds) of FMO3 
gene expression and downregulation (more than 10 folds) of MUP 4 gene expression 
in the liver of both wild-type and CRY 1,2 -/- mice. The expression of CYP4A14A 
was also induced by CR in both genotypes, but the induction was higher in CRY 1,2 
-/- mice. Thus, CRY’s were not necessary for regulation of the FMO3 and MUP4 gene 
expression by CR and CRY s contributed to the regulation of the CYP4A14A gene 
expression (Figure 4-5 a, b, c, d). On separate note, we also observed a significant 
difference in FMO3 gene expression between genotypes under AL conditions: in the 
liver of CRY 1,2 -/- mice the expression was higher at several time points, however, 
the magnitude of the induction was not as dramatic as the effect of CR: about 6 folds 
of difference between WT and CRY  1,2 -/- mice and more than 300 folds of difference 
between mice on AL and CR diets. 
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Figure 4-5. Effect of calorie restriction on rhythms of longevity-associated genes. 
mRNA expression of longevity-associated genes (A) FMO3, (B) MUP4, (C) 
CYP4A14A, (D) CYP4A12B. WT CR (Green triangle), CRY 1,2 -/- AL (Red square), 
CRY  1,2 -/- CR (Dark Blue). Data represent mean ± SD; statistically significant (p < 
0.05) effects of the feeding (analyzed by two ways ANOVA) at a given time point are 
indicated by (a)- between WT AL and WT CR groups, (b)- WT AL and CRY  1,2 -/- AL, 
(c)- WT CR and CRY  1,2 -/- CR, (d)- CRY  1,2 -/- AL and CRY  1,2 -/- CR. Light and 
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dark bars at the bottom represent light and dark phase of the day. ZT0 is the time when 
the light is on and ZT12 is the time when the light is off. 
 
CRY’s contribute to CR-induced downregulation of circulating IGF-1 level and 
IGF signaling 
We have reported that CRY’s are the important regulator of plasma IGF-1 level and 
IGF signaling in mammals. Reduced level of CRY 1 protein in response to 30% CR 
led us to a hypothesis that CRY’s are involved in the CR-induced downregulation of 
IGF-1.  We assayed the levels of IGF-1 in the plasma of WT AL, WT CR, CRY 1,2 -
/- AL, and CRY  1,2 -/- CR mice. As it was previously reported the levels of the 
circulating IGF-1 demonstrated statistically significant daily changes (Figure 4-6 a). 
Also in agreement with previously published data, the levels of the circulating IGF-1 
were low in both WT CR and CRY 1,2 -/- AL mice. The circulating IGF-1 levels in 
WT AL mice were statistically significantly different from IGF-1 levels in WT CR, 
CRY  1,2 -/- AL or CRY  1,2 -/- CR mice at all 6 times of the day.  No significant 
difference was observed between levels of the circulating IGF-1 between WT CR, 
CRY 1,2 -/- AL and CRY  1,2 -/- CR mice. Thus, CRY’s are necessary for the CR-
induced downregulation of circulating IGF-1. 
The reduced IGF-1 level in CRY  1,2 -/- mice is associated with the reduced IGF 
signaling in the skeletal muscles, therefore, we decided to investigate if CRY’s are 
necessary for suppression of IGF signaling upon CR. Reduced IGF-1 signaling results 
in the increased transcriptional activity of transcriptional factor FOXO. We monitored 
the expression of two known FOXO targets Murf-1 and Myogenin in the skeletal 
muscles. As illustrated on (Figure 4-6 b, c) the expression of both genes is 
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significantly lower in WT AL mice than in WT CR or CRY  1,2 -/- AL mice at several 
times of the days; CR did not have any significant effect on the expression of these 
genes in the skeletal muscles of CRY  1,2 -/- mice. Thus, CRY’s were important for 
down regulation of IGF-1 level and IGF signaling upon CR. 
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Figure 4-6. Effect of calorie restriction on circulating IGF1 level and IGF1 signaling 
in skeletal muscle. (a) Plasma IGF1, mRNA expression of (b) Murf1 and (c) Myogenin 
in skeletal muscle.  WT AL (Blue diamond), WT CR (Green triangle), CRY  1,2 -/- AL 
(Red square), CRY  1,2 -/- CR (Dark Blue). Data represent mean ± SD; statistically 
significant (p < 0.05) effects of the feeding (analyzed by two ways ANOVA) at a given 
time point are indicated by (a)- between WT AL and WT CR groups, (b)- WT AL and 
CRY  1,2 -/- AL, (c)- WT CR and CRY  1,2 -/- CR, (d)- CRY  1,2 -/- AL and CRY  1,2 -
/- CR. Light and dark bars at the bottom represent light and dark phase of the day. ZT0 is 
the time when the light is on and ZT12 is the time when the light is off. 
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CRY’s regulate CR-induced downregulation of IGF-1 mRNA expression  
It was proposed that reduction of circulating IGF-1 upon CR is due to reduced IGF-1 
mRNA expression in the liver (Herrington et al. 2000). We previously reported that 
CRY’s regulate the expression of IGF-1 gene on mRNA level (Chaudhari et al. 2016).  
We compared the expression of IGF-1 on the mRNA level across the circadian cycle 
in the liver of WT and CRY 1,2 -/- mice on both AL and CR diets (Figure 4-7 a). In 
agreement with previous reports, both 30% CR in wild-type mice and CRY’s 
deficiency resulted in the significant reduction of IGF-1 mRNA expression (the 
difference was significant at several times of the day), no further significant reduction 
in the expression was observed CRY 1,2 -/- mice on CR diet. The majority of the 
circulating IGF-1 is produced in the liver (Yakar et al. 1999) but other tissues also 
produce IGF-1, which is essential for the paracrine signaling (Liu et al. 1998). IGF-1 
mRNA expression was reduced upon 30% CR in the skeletal muscles of WT mice 
(Figure 4-7 b); in CRY  1,2 -/- mice the IGF-1 expression was significantly lower 
than in WT and it was not affected by CR. Thus, the reduction of IGF-1 mRNA 
expression in response to 30% CR was dependent on CRY’s in both tested tissues. 
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Figure 4-7. Calorie restriction affects the IGF1 expression in (a) Liver and in (b) 
Skeletal muscle.  Data represent mean ± SD; statistically significant (p < 0.05) effects of 
the feeding (analyzed by two ways ANOVA) at a given time point are indicated by (a)- 
between WT AL and WT CR groups, (b)- WT AL and CRY  1,2 -/- AL, (c)- WT CR and 
CRY  1,2 -/- CR, (d)- CRY  1,2 -/- AL and CRY  1,2 -/- CR. Light and dark bars at the 
bottom represent light and dark phase of the day. ZT0 is the time when the light is on and 
ZT12 is the time when the light is off. 
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Effect of CR on JAK2-STAT5B signaling  
IGF-1 transcription in the liver is regulated by the transcriptional factor STAT5B 
(Herrington et al. 2000). According to the existing paradigm STAT5B is 
phosphorylated and active under AL conditions and upon CR both phosphorylation 
and transcriptional activity of STAT5B is dramatically reduced (by unknown 
mechanisms), which causes a reduction in IGF-1 transcription (Oberbauer. 2013). We 
assayed the levels of STAT5B phosphorylation on Y699 (used as a marker of 
STAT5B activation) in mice of both genotypes on both diets across the clock. As it 
was expected upon 30% CR, in WT mice the STAT5B phosphorylation was 
dramatically reduced at several times of the day, which is generally is in an agreement 
with the previously published data on the effects of CR on STAT5B phosphorylation 
(Figure 4-8 a). In the liver of CRY 1,2 -/- mice, the STAT5B phosphorylation was 
significantly affected by 30% CR only at one time ZT18, at all other times of the day, 
the effect of CR on STAT5B phosphorylation was not significant (Figure 4-8 b). 
Please note that the level of the STAT5B phosphorylation was significantly lower in 
the liver of CRY 1,2 -/- mice as we previously reported. 
 
The phosphorylation of STAT5B is regulated by a JAK2 kinase. In the liver of WT 
mice, CR resulted in a small but significant increase in JAK2 phosphorylation (Figure 
4-8 a) and in the liver of CRY 1,2 -/- mice no significant difference in JAK2 
phosphorylation was observed (Figure 4-8 b). Thus, the reduced phosphorylation of 
STAT5B upon CR in WT mice was not a consequence of reduced JAK2 
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phosphorylation, in agreement with previous reports, and CRY s did not regulate 
JAK2 phosphorylation under CR and, most likely, act downstream of JAK2. 
 
Figure 4-8. Effect of calorie restriction on JAK2-STAT5B activity. (a) Representative 
Western blot analysis of p-JAK2 and p-STAT5B in the liver of WT AL compared to WT 
CR (A) and in CRY 1,2 -/- AL compared to CRY  1,2 -/- CR (B). (C) Respective 
quantification of phosphorylation of STAT5B on Y699 and (D) JAK2 on Y1007. WT AL 
(Blue diamond), WT CR (Green triangle), CRY  1,2 -/- AL (Red square), CRY  1,2 -/- 
CR (Dark Blue). Data represent mean ± SD; statistically significant (p < 0.05) effects of 
the feeding (analyzed by two-way ANOVA) at a given time point are indicated by (a)- 
between WT AL and WT CR groups, (b)- WT AL and CRY  1,2 -/- AL, (c)- WT CR and 
CRY  1,2 -/- CR, (d)- CRY  1,2 -/- AL and CRY  1,2 -/- CR. Light and dark bars at the 
bottom represent light and dark phase of the day. ZT0 is the time when the light is on and 
ZT12 is the time when the light is off.  
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In an agreement with the effect of CR on the STAT5B phosphorylation, the mRNA 
expression of STAT5B target gene ALS (Acid labile subunit) was down regulated by 
CR in the liver of WT but not CRY 1,2 -/- mice.  (Figure 4-9).   
 
Figure 4-9. mRNA expression of STAT5B target gene ALS in the liver.  WT AL (Blue 
diamond), WT CR (Green triangle), CRY  1,2 -/- AL (Red square), CRY  1,2 -/- CR (Dark 
Blue). Data represent mean ± SD; statistically significant (p < 0.05) effects of the feeding 
(analyzed by two ways ANOVA) at a given time point are indicated by: (a)- between WT 
AL and WT CR groups, (b)- WT AL and CRY  1,2 -/- AL, (c)- WT CR and CRY  1,2 -/- 
CR, (d)- CRY  1,2 -/- AL and CRY  1,2 -/- CR. Light and dark bars at the bottom represent 
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light and dark phase of the day. ZT0 is the time when the light is on and ZT12 is the time 
when the light is off. 
 
 
 
 
Up-regulation of CISH mRNA and protein expression upon CR is CRY-
dependent  
The activity and phosphorylation of STAT5B are regulated by the proteins from 
SOCS family. We previously reported that the expression of CISH is significantly up-
regulated in the liver of CRY 1,2 -/- mice. 30% CR significantly induced the 
expression of CISH, the induction was from 5 to 30 folds depending on the time of 
the day. In contrast to that, the expression of CISH was not significantly affected by 
CR in the liver of CRY 1,2 -/- mice. In agreement with the protein data the mRNA 
expression for CISH was high in the liver of CRY 1,2 -/- mice and it was not affected 
by CR (Figure 4-10 a, right). The CISH mRNA expression was significantly induced 
at multiple time of the day upon CR in WT mice (Figure 4-11 D). Thus, CISH 
expression was regulated by the CR in the liver in CRY-dependent manner. Upon 
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30% CR, the expressions of SOCS1 and SOCS3 proteins were significantly reduced 
in the liver of WT mice at multiple times of the day and the reduction correlated with 
decreased mRNA expression of both genes (Figure 4-11 A, C, left). In CRY  1,2 -/- 
mice 30% CR had some significant but mixed effect on the expression of these two 
proteins, for SOCS1 protein CR resulted in reduced expression at ZT6 and ZT 10 and 
increased expression at ZT18; for SOCS3 protein CR resulted in increased expression 
at ZT10. We did not detect any significant effect of CR on the mRNA expression of 
these two genes in the liver of CRY 1,2 -/- mice (Figure 4-11). 
 
SOCS1 and SOCS3 are known transcriptional targets of STAT5B and the reduced 
mRNA expression in the liver of CR or CRY 1,2 -/- mice correlated with the reduced 
STAT5B phosphorylation. The expression of the SOCS2 protein was also affected by 
CR in both WT and CRY 1,2 -/- mice, but the effect was mixed, we observe up or 
down regulation of the expression at different times of the day. We did not detect any 
significant effect of the diet on genotype on the expression of Socs2 mRNA.  
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Figure 4-10. Effect of CR SOCS’s protein. (a) Representative western blotting in WT 
AL compared to WT CR and (b) CRY 1,2 -/- AL compared to CRY  1,2 -/- CR in the 
liver. Quantification of expression (c) SOCS1, (d) SOCS2, (e) SOCS3 and (f) CISH. WT 
AL (Blue diamond), WT CR (Green triangle), CRY  1,2 -/- AL (Red square), CRY  1,2 -
/- CR (Dark Blue). Data represent mean ± SD; statistically significant (p < 0.05) effects 
of the feeding (analyzed by two ways ANOVA) at a given time point  
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Figure 4-11. Daily profiles of mRNA expression of indicated SOCS family member 
genes in the liver of WT AL (blue diamonds), WT CR (green triangle), CRY  1,2 -/- AL 
(Red squares) and CRY  1,2 -/- CR (Dark Blue square) male mice (N = 3 per time point). 
Data represent mean ± SD; statistically significant (p < 0.05) effects of the feeding 
(analyzed by two ways ANOVA) at a given time point are indicated by (a)- between WT 
AL and WT CR groups, (b)- WT AL and CRY  1,2 -/- AL, (c)- WT CR and CRY  1,2 -/- 
CR, (d)- CRY  1,2 -/- AL and CRY  1,2 -/- CR. Light and dark bars at the bottom represent 
light and dark phase of the day. ZT0 is the time when the light is on and ZT12 is the time 
when the light is off. 
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4.5 Discussion 
Cryptochromes are necessary for CR-mediated downregulation of IGF-1 
expression  
CR leads to the downregulation of IGF-1 production and IGF signaling. IGF 
signaling plays an important conserved role in the longevity. In mammals, one of the 
main beneficial effects of CR is significantly reduced cancer rate. It was demonstrated 
that reduced cancer rate is mostly due to the reduced IGF signaling. Therefore, 
understanding molecular mechanisms of downregulation of IGF-1 production upon 
CR is extremely important. Upon CR the expression of Igf-1 mRNA is reduced in the 
liver and other metabolic tissues. The activating phosphorylation of transcriptional 
factor STAT5B, a major regulator of Igf-1 expression, is also significantly reduced  
At the same time, GH level is not reduced (Bruss et al. 2011) and GH-dependent 
phosphorylation of JAK2 is not reduced. Based on these data it was proposed that CR 
affects the signaling between JAK2 and STAT5B (Thompson et al. 2014), but 
mechanisms are unknown. 
We found that CR did not reduce plasma IGF-1 level and Igf-1 mRNA 
expression in Cry1,2-/- mice.  Importantly, while the levels of plasma IGF-1and Igf-
1 mRNA expression is low in Cry 1,2-/- mice on both diets, it is not zero (the daily 
levels of plasma IGF-1 are between 400 ng/ml and 1400 ng/ml in wild-type mice on 
AL diet and between 200 ng/ml and 300 ng/ml in Cry1,2-/- mice on both diets and in 
wild-type mice on CR diet), this level can be further reduced for example by 
prolonging fasting (as low as 100 ng/ml). In wild-type animals, CR resulted in the 
109 
 
increased expression of CISH on both mRNA and protein levels, while in Cry1,2-/- 
mice CR did not lead to further upregulation of CISH expression, therefore, CRY’s 
are necessary for the induction of CISH expression by CR. In wild-type mice, the 
increased CISH expression correlated with the reduced phosphorylation of STAT5B, 
while Cry1,2-/- mice there is no significant effect of CR on STAT5B phosphorylation. 
Thus, we hypothesized here that CR regulates downregulation of IGF-1 expression 
through CRY-dependent control of CISH expression, however, we cannot exclude 
that there are CRY and CISH- independent mechanisms.  To test this hypothesis 
directly we need to investigate the effect of CR on CISH deficient mice, which is 
future study. 
 
CR regulates the expression of Cryptochrome proteins  
We found that CRY 1 protein level was reduced upon CR in the liver and 
skeletal muscles of WT mice. This downregulation was due to some 
posttranscriptional regulation because CRY 1 mRNA expression was not affected. 
Emerging evidence suggests the importance of CRY’s posttranslational regulation for 
circadian clock function. CRY’s are phosphorylated by AMPK, and this 
phosphorylation leads to CRY’s degradation (Lamia et al. 2009). AMPK is implicated 
as a molecular mediator of CR, but data on its induction by CR are controversial 
(Cantó and Auwerx 2011). In separate studies, ubiquitin ligases involved in CRY 1 
degradation have been reported (Yoo et al. 2013). If these signaling systems are 
involved in the observed reduction of CRY’s level upon CR or not needs to be studied. 
Interestingly, in a contrast to the effect on CRY 1, the expression of CRY 2 was not 
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reduced upon CR and even there was some increase in the expression, which suggests 
different regulation of these two highly homologous proteins. 
Previously we demonstrated that deficiency of both proteins is necessary for 
reduced body size downregulation of IGF-1 production. How in this case 
downregulation only CRY 1 could be sufficient for the downregulation of IGF1 
production upon CR in WT mice? Deficiency of CRY 1 results in the modest but 
statistically significant reduction in circulating IGF-1 level, but the effect is not as 
strong as deficiency of both proteins. Deficiency of CRY 2 does not have any effect 
on the level of circulating IGF-1. There is evidence that CRY 1 and CRY 2 have 
partially redundant functions: for example, their role in the circadian clock 
mechanisms is not identical - deficiency of individual proteins results in shorter (CRY 
deficiency) or longer (CRY deficiency) and deficiency of both in rhythms disruption; 
CRY 2 is implicated as tumor suppressor but CRY 1 is not. CRY 1 and CRY 2 also 
have a different pattern of tissue expression. It is possible that embryonic deficiency 
of either protein can be, at least partially, compensated during development, which is 
often observed for the proteins with redundant functions, when during the 
development compensatory proteins start to express in the tissue where normally 
homologous protein is expressed predominantly. Down-regulation of the protein 
expression in the adult animal cannot be efficiently compensated. The future 
experiments with CR applied to Cry 1-/- and Cry 2-/- mice will help to understand the 
role of individual CRY proteins in CR-dependent down regulation of IGF-1 
production.       
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CR regulates IGF-1 production through Cryptochrome/CISH dependent 
mechanism. Model 
We propose the following model (Figure 4-12). Under AL conditions CRY’s 
suppresses the expression of CISH on both mRNA and protein level. When CISH 
expression is low GH/GHR/JAK2 signaling is active and STAT5B is recruited to the 
phosphorylated GHR, where it is phosphorylated by JAK2. After that activated 
STAT5B forms a dimer, translocate to the nucleus where it will drive the expression 
of targets genes including IGF-1. Under CR conditions CRY 1 protein expression is 
down-regulated, which releases the suppression of CISH expression. CISH inhibits 
the interaction between STAT5B and GHR, thus, inhibiting STAT5B phosphorylation 
and activity. As consequence, the expression IGF-1 mRNA is significantly reduced, 
which caused the reduced level of serum IGF-1, reduced IGF signaling and, 
ultimately, will contribute to the reduced cancer rate under CR. 
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Figure 4-12: Proposed model for the role of Cryptochrome in IGF-1 production and 
calorie restriction-mediated mechanism.  
The solid line represents previously reported activation of STAT5B phosphorylation 
by JAK2 and suppression of this phosphorylation by CISH members of SOCSs 
family. Under AL condition level of CRY’s is high and CRY’s might directly interact 
with JAK2 containing complexes and stimulate JAK2 activity toward STAT5B, CRY 
might recruit STAT5B to the JAK2/GHR complex, CRY might also suppress CISH 
expression/activity. Thus, high level of CRY’s stimulates STAT5B phosphorylation 
and activation, which in turn, drives IGF-1 expression in the liver and other tissues. 
Under CR conditions level of CRY’s in the tissues is significantly reduced, which 
compromises the above-proposed mechanisms and leads in reduced JAK2 activity 
toward STAT5, as a result, the IGF-1 expression is reduced. 
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FUTURE IMPLICATIONS  
We found that Cryptochromes are important regulators of CISH expression 
and IGF-1 production and signaling under AL conditions and these proteins are 
necessary for CR-induced downregulation of IGF-1 expression. IGF signaling plays 
an important role in the development of cancer and in control of longevity. Thus, it 
would be interesting to examine the effect of CR on longevity and cancer development in 
CRY-deficient mice. 
 Another direction is regulation of JAK2/STAT signaling by Cryptochromes, we 
found that GH-dependent phosphorylation of STAT5B is dependent on CRY’s, most 
likely, through the control of CISH expression. CISH is involved in the regulation of 
phosphorylation of other STAT transcriptional factors such as STAT3 in response to 
different cytokines such as EPO and IL-2. 
Finally, an important question is how CR regulates Cryptochrome expression on 
translational and posttranslational levels. It would be interesting to study ubiquitination 
by different ubiquitin ligases such as Fbxl3 and Fbxl21 that are known to target these 
proteins for proteasome-mediated degradation. Since AMPK is a kinase which has been 
demonstrated to be affected by CR and while it is also involved in CRY degradation 
process, understanding the AMPK pathway regulated CRY degradation would be another 
important study. 
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CHAPTER V 
CONCLUSION 
 
 
1. Cryptochromes regulated the IGF-1 production and IGF signaling, reduced IGF-
1 production in Cry1,2 -/- mice correlated with the reduced body size and body 
weight of these mice. We proposed that the circadian clock-dependent control of 
IGF signaling through CRY-dependent mechanism is important for the 
synchronization of cell growth and proliferation with rhythms in metabolism, 
daily activity, and feeding. 
2. Cryptochromes suppressed the expression of CISH on both mRNA and protein 
levels. Up-regulation of CISH correlated with the reduced phosphorylation of 
transcriptional factor STAT5B and might be responsible for the reduced Igf-1 
expression. Cryptochromes might be involved in the control of JAK2/STAT 
signaling through the regulation of CISH expression. Thus, Cryptochromes might 
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regulate many other physiological systems and processes such as immune 
response. 
3. CR regulated CRY1 expression on the protein level, thus linking the diet with the 
circadian clock mechanism. 
4. Cryptochromes are necessary for calorie restriction induced downregulation of 
IGF-1 production. IGF signaling plays the central role in cancer development and 
longevity under CR conditions. Our results suggest that Cryptochromes are 
essential components of CR molecular mechanism and might be involved in the 
control of carcinogenesis and longevity in mammals.  
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Table 1. Cosinor Wave Analysis in (A) WT AL and WT CR., (B) CRY 1,2 -/- AL and 
CRY 1,2-/- CR. The circadian parameters were assessed by the cosinor analysis that 
models the circadian rhythms (Circa) as a cosine function with the following attributes: 
amplitude (amp), and acrophase (acr). 
 
CIRC: CIRCAIDAN, ACRO: ACROPHASE , AMP: AMPLITUDE   
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A. 
 
 
 
 
 
 
 
           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GENOTYPE
/DIET 
 
WT AL 
 
WT CR 
  
CIRC 
 
Acro 
 
Amp 
 
CIRC 
 
 
Acro 
 
Amp 
BMAL1 YES 22.91635    18.59649 
 
YES 23.56465 8.32047 
 
PER1 YES 14.43865 6.88812 
 
YES 11.06454 20.28089 
 
PER2 YES 15.02812   5.326099 
 
YES 14.27397 17.25972 
 
FMO3 NO 13.83491 3.441873 
 
YES 12.23519 1.784454 
 
MUP 4 YES 11.85188 1.492938 
 
YES 8.08063 3.853585 
 
CYP4A14A YES 5.474312         15.16344 
 
NO 10.45299           3.627251 
 
CYP4A12B 
 
 
YES 9.754743           3.545335 
 
YES 12.60116            22.51527 
 
ALS YES 2.408401                1.806876 
 
NO 16.07329            1.369674 
 
IGFBP-3 YES 2.501775             1.787465 
 
YES 1.582492             1.404963 
 
IGF1 YES 18.37578       3.162794 
 
YES 20.3743         2.345746 
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B. 
GENOTYPE/DIET CRY AL CRY CR 
CIRC Acro Amp CIRC Acro Amp 
BMAL1 YES 5.460247 1.533264 NO 16.8326 2.36377 
PER1 NO 2.321969 4.027954 YES 9.593249 3.816822 
PER2 YES 7.891592 2.515398 YES 14.37423 1.917164 
FMO3 NO 21.78263      20.97115 YES 8.734285 2.528742 
MUP 4 YES 5.426368 3.461747 NO 12.10274  4.765915 
CYP4A14A NO 15.97276       22.05058 YES 11.33757       3.616333 
CYP4A12B YES 8.870595       55.96446 YES 12.80597     40.7383 
ALS YES 18.98527       2.64 YES 19.75206       1.901505 
IGFBP-3 YES 3.170331      1.72 YES 4.144528       1.94486 
IGF1 YES 21.34849       1.355818 YES 5.68356      1.627443 
